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Abstract
Plants are an attractive host system for pharmaceutical protein production. Many
therapeutic proteins have been produced and scaled up in plants at a low cost compared to
the conventional microbial and animal based systems. The main technical challenge
during this process is to produce sufficient level of proteins in plants. Low yield is
generally caused by proteolytic degradation during expression and downstream
processing of recombinant proteins. The yield of a human therapeutic protein interleukin
(IL) -10 produced in transgenic tobacco leaves was found to be below the critical level,
and is potentially due to degradation by tobacco cysteine proteases (CysPs). A total of 60
putative CysP genes were identified in tobacco and based on their expression in the leaf
tissue, 10 candidate CysPs (CysP1-CysP10) were selected for further characterization.
The effects of silencing and overexpressing these CysPs on IL-10 accumulation were
examined in tobacco. It was found that the recombinant protein yield in tobacco could be
increased by stably silencing CysP6. Transient expression of CysP6 silencing construct
also showed an increase in IL-10 accumulation in comparison to the controls. Moreover,
CysP6 is localized to the Endoplasmic Reticulum (ER), suggesting that ER is the
potential site of IL-10 degradation. Overall results suggest that CysP6 is involved in
determining the yield of recombinant IL-10 in tobacco.
Key Words
Cysteine protease, tobacco, Interleukin-10, protein degradation, endoplasmic reticulum,
silencing, ELISA
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Chapter 1: Introduction
1.1 Recombinant protein production systems
Recombinant proteins are protein molecules such as vaccines, antibodies,
enzymes, cytokines and hormones which are produced in a system other than the native
biological hosts. Such proteins are widely used in prophylaxis or treatment of diseases,
agricultural crop improvement and industrial applications. Recombinant therapeutics and
neutraceutical proteins have a strong market demand and their production account for
multi-billion dollar market volume in recent days (Durocher and Butler, 2009).
Availability of the engineered bacterial strains and/or transgenic plants and animals has
provided rapid advancement in large scale production of recombinant proteins. This
advancement has resulted in increased accessibility to products that were not available or
less safe to produce 20 years back. The impact of recombinant protein has been further
extended by the development of industrial enzymes, diagnostic kits and biological control
agents and continues to grow as applications in the field of detergent production and food
processing have met with notable successes (Palomares et al., 2004).
Recombinant proteins are produced in a variety of production systems ranging
from prokaryotic systems such as bacteria to eukaryotic systems such as yeast,
filamentous fungi, plants and animals. Escherichia coli and Bacillus subtillis are two
widely used bacterial hosts for producing therapeutic proteins and industrial enzymes. A
prominent therapeutic protein, human insulin, and a food processing enzyme, α-amylase,
are produced in bacterial host system (Ma et al., 2003). Though well utilized for large
scale production of many pharmaceutical proteins, bacterial systems are often
disadvantageous because of the inability to synthesize and modify complex eukaryotic
proteins. Proteins that require post-translational modifications (PTM) like glycosylation,
carboxylation and phosphorylation cannot be processed in bacteria. PTM profoundly
affects the biological activity of recombinant proteins and other properties relevant to
their therapeutic application. Nearly 70% of the recombinant proteins that are in clinical
trials at present, require glycosylation in their native form (Durocher and Butler, 2009).
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In addition, recombinant proteins can be toxic to bacteria, form protein inclusion bodies
during culture or get degraded by extracellular bacterial proteases.
Animal cell cultures and yeasts are currently widely employed for the production
of many complex proteins because of their ability to perform PTM. However,
recombinant proteins produced from animal cell cultures are expensive and carry an
inherent risk from contaminants of animal origin (Lienard et al., 2007). These
contaminants include blood-borne pathogens such as animal viruses or prions and thus,
the produced proteins require cautious downstream processing and quality control.
Transgenic animals are also commonly used to produce recombinant proteins, which
carry similar risks as cell culture systems. The risks from transgenic animal systems are
generally due to recombinant proteins which originate from the sources such as milk,
blood and egg white (Wang et al., 2013). Yeasts, on the other hand, have a potential of
synthesizing large amounts of mature recombinant proteins. Being an eukaryote, yeasts
are expected to have some advantages over bacteria. However, in many cases yeasts were
shown to inappropriately fold and secrete monoclonal antibodies (Houdebine, 2009) and
some yeasts did not glycosylate proteins or added sugars that were not found in native
proteins (Hamilton et al., 2003).
Transgenic plants are one of the most economical systems for the production of
recombinant proteins of industrial and therapeutic use (Ma et al., 2003). In addition,
plants have the ability to perform the majority of PTM’s required for correct folding and
assembly of eukaryotic multimeric proteins. The process of transgenesis is relatively easy
in plants and foreign proteins can be stored in leaves, root and seeds. With the abundant
biomass, the amount of protein that can be produced in plant is virtually unlimited.
Moreover, agriculture offers great flexibility for scaling up. Combined with these major
qualities and with genetic tools available for continuous improvement, plants offer a
unique and safer platform than any other existing host systems for recombinant protein
production.
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1.2 Recombinant protein expression in plants
Plants are attractive biofactories for recombinant protein expression. They offer
several advantages such as reduction in cost of production and increased scalability over
microbial and mammalian cell culture systems. The low cost of large scale production is
due to significant reduction in capital investment and running cost, as plants do not
require huge fermenters as cell culture based systems or highly skilled personnel to
operate them. It is estimated that recombinant proteins can be produced in plants at 210% of the cost required to produce them in microbial systems and at 0.1% of the cost
required to produce in animal cell cultures, although the cost of production may differ
depending on the specific protein (Kusnadi et al., 1997). A comparative cost evaluation
of producing monoclonal antibody Immunoglobulin (Ig) A in different host systems is
shown in Figure 1.1. It was found that, producing purified IgA using either green plant
biomass or grain significantly undercuts the cost of production using either animal cell
culture or transgenic animals (Daniell et al., 2001).
Recombinant proteins produced in plants are correctly assembled, functionally
matured and glycosylated. Plants are capable of adding high-mannose type N-glycans,
which are typical of mammalian glycoproteins (Cabanes-Macheteau et al., 1999; Bakker
et al., 2001). Some concerns have been raised regarding PTM occurring in plants,
especially immunogenicity caused by plant-specific glycosylations (Cabanes-Macheteau
et al., 1999). However, remarkable achievements have been made in modifying plantspecific glycans and removing enzymatic pathways which generate immunogenic
residues on glycoproteins (Paccalet et al., 2007; Decker and Reski, 2008; Sourrouille et
al., 2008; Strasser et al., 2008). Moreover, despite differences in N-glycan structures,
antibodies produced in plants have shown similar stability and antigen binding capacity
as their homologs produced in animal cells (Khoudi et al., 1999; Bouquin et al., 2002).
Besides low cost of production and efficient PTM’s of recombinant proteins, other
potential advantages offered by plants include reduced risk of contamination from
animal-borne pathogens and high level production of proteins using improved molecular
techniques that are easily adapted by plants (Kaldis et al., 2013).
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Figure 1.1: Estimated cost of purified IgA antibody produced by different
expression systems. The cost is plotted as a function of starting product concentration
before recovery and purification. Costs for mammalian cell culture were derived from
industry cost and purification facilities. Costs for transgenic goats were obtained from
Genezyme Transgenics (Farmingham, MA, USA). Costs for plants compare green
biomass (120.0 tonne ha-1) and seed production (7.5 tonne ha-1). Cost differences reflect
mainly the different costs of production: the cost of purification and the extent of product
loss during downstream processing were assumed to be the same for all systems. Adapted
from Daniell et al., (2001).
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Different plants have been used for recombinant protein production over the past
two decades. This includes a wide range of food and non-food crops like tobacco, alfalfa,
cereals (rice and maize), legumes (soybean) and fruits and vegetables (carrot, tomato,
potato) (Ma et al., 2003). Tobacco (Nicotiana tabacum) is the most widely used plant
host and has an established history in recombinant protein production. Being an easily
available, non-food crop, tobacco offers a competitive edge over any other plant host in
terms of large scale production. The primary advantage of tobacco is the presence of
well-established genetic tools for transfer and expression of foreign genes. Furthermore,
tobacco provides a high yield of protein per green leaf biomass, can be harvested 3-4
times in a year and has a prolific seed production ability (Ma et al., 2003). Since tobacco
is not a food or feed crop, the risk of food chain contamination via transgene escape is
also limited. The first pharmaceutical protein produced in plant, human growth hormone
(hGH), was expressed in the tobacco leaves (Barta et al., 1986). To increase the stability
of hGH transcript and achieve an efficient translation into protein, the expression of hGH
was driven by the promoter of NOPALINE SYNTHASE gene and polyadenylation sites
were added to the hGH gene sequence. Since then, many recombinant proteins like
monoclonal antibodies (IgG, IgA and IgM) and recombinant subunit vaccines (hepatitis
B, E. coli enterotoxin and Cholera toxin B) have been successfully produced in tobacco
and are in different stages of the clinical trials (Ma et al., 2003; Lienard et al., 2007).
Other biopharmaceutical proteins produced in tobacco include plasma proteins, animal
hormones and cytokines, which are used to improve blood and immune functions
(Lienard et al., 2007). Some of the examples of such biopharmaceuticals are human
albumin, erythropoietin and interleukins. As tobacco has been criticized for its high toxic
alkaloid level, low alkaloid tobacco cultivar (cv. 81V9) has been established and can be
efficiently used for production of recombinant proteins (Menassa et al., 2001).
1.3 Stable and transient protein expression systems
There are two main methods used for recombinant protein expression in plants:
stable and transient transformations. Stable transformation of plants allows heritable
integration of a transgene into the plant genetic material and consequently the acquired
character is passed on to next generation. With transient transformation, the expression of
5

transgene is short-lived and the acquired trait is not transmissible to the next generation.
Both strategies have been used widely for research and commercial production of
recombinant proteins (Lienard et al., 2007).
Stable protein expression can be achieved by transformation of nuclear and plastid
(chloroplast) genomes. This strategy has been used for a great variety of plant species
such as rice (He et al., 2011), potato (Scheller et al., 2001), tomato (Pan et al., 2008) and
tobacco (Staub et al., 2000). Stable nuclear transformants can be generated by
transformation using the gram-negative bacterium, Agrobacterium tumefaciens. Using
well-established transformation protocols, exogenous DNA can be inserted into a Tumor
inducing (Ti) plasmid of Agrobacterium and delivered into the plant tissues for
production of the desired protein (McCormick et al., 1986; Lienard et al., 2007).
Alternatively, metal particles coated with exogenous naked DNA can also be shot into the
nuclear genome using a gene gun (Christou, 1995). Nuclear transformation allows for
regeneration of transgenic lines, followed by extraction and purification of proteins from
the transgenic tissues in multiple generations.
Stable transformation of the chloroplast genome can be accomplished using the
gene gun method. The advantages of chloroplast transformation include: a higher
transgene copy number due to the presence of high number of chloroplast in
photosynthetic cells and maternal inheritance of the chloroplast DNA which reduces risk
of transgene escape via pollen. Furthermore, there is limited toxicity to the plant cell as
proteins are produced and localized in the chloroplasts. In recent years, chloroplast
transformation has been reported to result in a remarkable yield of heterologous proteins
(Bock and Warzecha, 2010). However, chloroplasts are unable to perform typical
eukaryotic PTM, such as protein glycosylation. With a limited protein maturation
capacity, a chloroplast looks particularly well adapted for production of simple
eukaryotic proteins (Jobling et al., 2003). Chloroplast transformation has been
successfully attempted in very few plant species, primarily tobacco.
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Transient expression of proteins in plants has been successfully performed using
viral and non-viral expression vectors. Viral vectors are modified viral genomes which
serve as a vehicle to carry foreign genes and the genes are expressed in plants as the byproduct of viral replication. Recombinant proteins that have been produced using
classical plant virus expression systems utilize gene fusion with different viral coat
proteins (CP), or replacement of CP genes with the gene of interest, and are transferred
by viral infection to the plant (Kohl et al., 2006; Avesani et al., 2007). The second
generation viral vectors utilize Agrobacterium for transferring a proviral replicon
harbouring the gene of interest into the plant cells. The proviral replicon is constructed in
the transfer (T) - DNA region of the Ti plasmid, which is then transferred into plant host
such as Nicotiana benthamiana (Santi et al., 2006; Werner et al., 2011). The protein is
transiently expressed and harvested in approximately 2-14 days post-infiltration. Though
considered ideal for expression of vaccine antigens, viral vector systems have biosafety
issues regarding handling and use of virus originated material, and a cost disadvantage in
comparison to the stable protein expression.
Non-viral expression vectors carrying a foreign gene of interest have also been used
for transient expression of proteins in plants. It is commonly done by vacuum infiltration
of recombinant Agrobacterium culture into the host plant (Vaquero et al., 1999). N.
benthamiana is the most widely used host for this purpose, as its leaves are well suited
for infiltration of the bacterial culture and results in transient transformation of many
cells. A high level of protein can be transiently produced by large scale infiltration of N.
benthamiana and commercially it has been brought to use by different companies
(D'Aoust et al., 2008). However, using transient expression technique, higher yield of
proteins are only achieved for a short period of time. In addition, low biomass of the plant
hosts and lack of consistency between different batches of proteins are the major
concerns in commercial production of recombinant proteins using transient expression
systems.
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1.4 Challenges of recombinant protein production in plants
Recognized as an efficient and most economical system, plant bioreactors have
emerged as a reliable source for recombinant protein production. However, plant
bioreactors have two major concerns that limit the production of recombinant proteins.
First, lower accumulation levels of the proteins of interest, and second, lack of the
efficient protein purification methods. Recovery of proteins from plant biomass requires
multistep purification using chromatography, adsorption, precipitation and filtration, and
thus, is a delicate and costly process. In some cost analysis cases, it has been found that
purification steps account for more of the costs than production in a plant host
(Evangelista et al., 1998). However, pricing of the recombinant proteins is mostly
dependent on total yield provided by the production systems and final accumulation of
the proteins in their bioactive forms. Lower accumulation levels are generally observed,
which is mainly due to the lower level of transgene expression and protein instability
found during the expression and recovery of recombinant proteins.
Transgene expression in plants is affected by various factors and involves
regulation at different levels such as transcription, translation and post-translation. As a
result, nascent and steady state transcript levels, translational turnovers, and the final
levels of mature proteins do not co-relate to each other during recombinant protein
production (Chen et al., 2013). Different strategies have been employed to improve
transgene expressions in plants such as, using tissue specific promoters (Christensen and
Quail, 1996), suppressing a commonly occurring transgene silencing (Lombardi et al.,
2009), intron induced splicing of transcript messenger (m)RNA (Vain et al., 1996) and
modifying the 3’ and 5’ untranslated regions (UTR) of the gene for producing higher
transcript levels (Strizhov et al., 1996). Using these approaches, significant improvements
have been made in obtaining a higher recombinant protein yield, however, in many cases
the levels of recombinant protein accumulation still remain low at <1% of the total
soluble protein (TSP) (Doran, 2006). One of the major reasons for low yield is the
degradation of foreign protein by plant proteases (Faye et al., 2005; Doran, 2006).
Therefore, the low levels of protein accumulations result from a process of synthesis and
degradation occurring during protein expression in different systems.
8

Protein degradations in the plant systems are known to occur by both intracellular
and extracellular ways. Inside the cell, degradations can occur after synthesis, assembly
and in some cases during PTM in the Endoplasmic Reticulum (ER) and Golgi apparatus.
Outside the cell, proteins are degraded by extracellular proteases in the apoplastic space
or in the culture medium when they are synthesized as secreted proteins (Hehle et al.,
2011). Protein fragments have been found to form in many plant hosts expressing
recombinant proteins, such as in tobacco (De Neve et al., 1993; van Engelen et al., 1994;
Schiermeyer et al., 2005), Arabidopsis (De Neve et al., 1993), corn (Russell, 1999;
Russell et al., 2005), potato (Outchkourov et al., 2003) and alfalfa (Khoudi et al., 1999).
The evidences for foreign protein degradation in these plants were obtained from Western
blots using proteins present in the plant extracts. Cleavage products were also identified
for proteins such as human growth hormone (Russell et al., 2005), plasminogen activator
(Schiermeyer et al., 2005) and monoclonal antibody IgG1 (Sharp and Doran, 2001) using
peptide sequencing methods.
Since the yield of recombinant protein is severely affected by proteolytic
degradation, there is a large interest in identifying and addressing the cause of
proteolysis. Analyzing proteolysis events and characterizing protein fragments have
revealed information regarding cleavage sites and mechanism of some recombinant
protein degradation processes (Outchkourov et al., 2003). In one of the early studies,
degradation of IgG1 monoclonal antibody in tobacco hairy root and suspended cell
cultures was found to be caused by extracellular proteases (Sharp and Doran, 2001).
Analysis of protein fragments by western blot suggested that IgG1 was degraded not
during extraction but during synthesis and protein maturation along the secretory pathway
of plant cell. Later, identification of a specific class of plant protease responsible for the
proteolysis was successfully performed in many systems producing recombinant proteins.
It was found that in planta degradation of MGR48 monoclonal antibody, an IgG1 type
immunoglobulin from mouse, is catalyzed by acidic proteases in the apoplastic space
(Stevens et al., 2000). The degradation was more prominent in older leaves than in
younger leaves while a comparison was done by in-vitro incubation of recombinant IgG1
with crude leaf extracts. This study indicated that the proteases associated with aging or
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senescence, which also include the members of enzyme class cysteine proteases, are
involved in IgG1 degradation. Cysteine proteases were also identified as the enzymes
responsible for the degradation of recombinant sea anemone protein equistatin, during its
expression in potato tubers (Outchkourov et al., 2003). More recently a rice cysteine
protease, RETARDED PALEA1 (REP1), was also specifically found to degrade a human
cytokine (human granulocyte macrophage-colony stimulating factor) while the protein
was produced by secretion in rice cell suspension culture (Kim et al., 2008).
1.5 Strategies in improving protein yield
Although degradation of foreign protein in plants depend on different factors, it
has been found that proteolysis occurs to a greater extent in tobacco than any other plant
species such as Arabidopsis (De Neve et al., 1993) and alfalfa (Khoudi et al., 1999).
Since tobacco is used to produce many recombinant proteins, it is important to minimize
the protein degradation to achieve high levels of functional proteins. In whole tobacco
plant, degradation of recombinant protein has been correlated to leaf maturation and
senescence process (Stevens et al., 2000). Different strategies have been employed to
influence the cell protease activity as a tool to improve the final protein yields. Targeting
recombinant proteins to accumulate in the ER is one of the strategies used to minimize
the exposure of proteins to cytosolic and apoplastic proteases (Menassa et al., 2001).
Retention of proteins in the ER is helpful in their proper folding and maturation as ER
harbours molecular chaperones and stabilizing agents. Strategies that directly affect
protease activity have also been applied such as expressing companion protease
inhibitior, which was successful in increasing the recombinant protein yield by 35-40%
(Benchabane et al., 2009; Goulet et al., 2010). An efficient way to minimize protease
activity was also suggested which involves identifying the responsible proteases and
downregulating their expression that would allow for a sufficient accumulation of the
target recombinant proteins (Kim et al., 2008). Alternatively, protease cleavage sites can
also be identified and amino acids in the recombinant protein can be altered to minimize
degradation. However, this approach first requires the identification of specific protease
and cleavage sites in recombinant proteins, before the engineering of protease cleavage
sites can be done.
10

In addition to reducing protein degradation, some other strategies have also been
employed which are targeted to improve the recovery of recombinant proteins in plants.
These strategies include: localization of proteins to a separable component such as to the
embryo or oil bodies for an easier extraction, induction of protein bodies or secretion into
cell suspension media for an easier purification, and production as fusion proteins to
increasing the stability of the produced proteins (Gutierrez et al., 2013). Despite
improvements in protein recovery such strategies often encounter problems; some of
which have been reported during production of biopharmaceuticals as protein bodies or
fusion proteins (Menassa et al., 2007; Kaldis et al., 2013). Biological inactivity of the
fusion proteins were through animal feeding and cell lines functional assays.
1.6 Plant proteases
Plant proteases are a special class of enzymes involved in the degradation of
native or foreign proteins. Plants contain four different class of proteases which are
classified according to their catalytic site residues (van der Hoorn, 2008). These include:
serine proteases, aspartic acid proteases, metalloproteases and cysteine proteases (CysPs).
Serine proteases use the active site Ser as a nucleophile during catalytic reactions. With
over 200 members among 14 families, serine proteases are the largest class of proteolytic
enzymes in plants (van der Hoorn, 2008). The roles of serine proteases have been
functionally characterized in proteolytic activation of enzymes (ABNORMAL LEAF
SHAPE 1, ALE1 for the activation of the enzyme involved in embryogenesis in
Arabidopsis), regulation of biosynthetic reactions (SINAPOYLGLUCOSE
ACCUMULATOR 1 and 2, SNG1 and SNG2 in regulation of ester biosynthesis in
Arabidopsis), as well as in tissue specific roles (STOMATAL DENSITY AND
DISTRIBUTION 1, SDD1 for regulation of positional stomata development within leaf
epidermis in Arabidopsis) (Lehfeldt et al., 2000; Tanaka et al., 2001; Von Groll et al.,
2002).
Metalloproteases contain catalytic metal ions that activate water molecules for the
proteolytic reactions. Over 100 plant metalloproteases have been identified which belong
to the 19 different families (van der Hoorn, 2008). Metalloproteases are involved in
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different aspects of plant growth and responses such as nodulation, plastid differentiation,
regulation of shoot and root meristem size and thermo-tolerance (van der Hoorn, 2008).
Aspartic acid proteases are also the other class of proteases that support water molecules
for proteolysis. Two Asp residues are involved in binding to the water molecule which
forms the active site in the enzyme. Aspartic acid proteases are the second most abundant
plant proteases, with members divided into 3 large families (van der Hoorn, 2008). These
proteases are similar to pepsin, their animal counterpart, and some of their members are
involved in gametophyte survival and disease resistance signalling (e.g. Arabidopsis
Promotion of cell survival-PCS1 and Constitutive disease resistance 1-CDR1) (Xia et al.,
2004; Ge et al., 2005).
1.7 CysPs
CysPs are ubiquitous proteins found in organisms ranging from bacteria, fungi,
viruses to plants and animals. CysPs involve a cysteine sulfhydryl group in their catalytic
reactions and their optimum catalytic activity is seen in a pH range of 4-6.5 (Grzonka et
al., 2001). CysPs are involved in responses to many environmental and developmental
cues and represent one of the thoroughly investigated protease class in plants. Till now,
101 families of CysPs have been discovered which are listed in the MEROPS database
and almost half of them are present in viruses (http://merops.sanger.ac.uk/cgiin/family_index?type=P#C). Many of these enzymes are found in bacteria (family C10,
streptopain in Streptococcus pyogenes; family C25, gingipain R in Polyhyromonas
gingivalis) and fungi (family C1B, bleomycin hydrolase in yeast). In mammals, two main
groups of CysPs, calcium-dependent cytosolic calpains (family C2), and lysosomal
cathepsins (family C1A like, subfamily cathepsin B, C, F, H, K, L, M, N, S, T, V and W)
have been found and are known to maintain the homeostasis of the cell’s metabolism
(Grzonka et al., 2001). Another representative CysP group in mammals are caspases
(family C14), which play an important role in programmed cell death and hypersensitive
responses controlling the so-called apoptosis cascades (Woltering, 2004).
In plants, most of the CysPs discovered till date belong to the papain (C1A) and
legumain (C13) families, but caspases and calpains have also been found in plants. In
12

addition, otubains (family C12) have also been found in plants whose roles are similar to
their animal counterpart (Vierstra, 2003). Among all these categories of CysPs, the
papain family is the most widely characterized group and comprises of all peptidases
which are structurally related to the protein, papain. The proteins in this family are
recognized by the presence of two structural domains (Grzonka et al., 2001). As shown in
Figure 1.2A, the catalytic pocket of papain is present in the cleft which is formed between
the two domains. Figure 1.2B shows that, the substrate pocket of papain consists of at
least 7 subsites which bind with 7 amino acid residues of the substrate for catalysis
(Schechter and Berger, 2012). However, previous studies have concluded that only 5
subsites of the enzyme (S1,S2,S3, S1’ and S2’) are necessary for substrate binding (Turk et
al., 1998). The enzymatic activity of papain is dependent on the presence of a Cys, His
and Asn residue, which form a catalytic triad of the enzyme. Asn in the catalytic triad is
present as the conserved amino acid residue across all papain family CysPs and is
important for the proper orientation of the His side chain (Beers et al., 2004). It has been
found that, the members of the papain CysPs preferentially cleave peptide bonds with
Arg in P1 position or Phe at the P2 position, in a pH interval of 3.5-8 (Grudkowska and
Zagdanska, 2004).
The otubain (OTU) is the most recently characterized family of CysPs in plants.
Little is known regarding the functional roles of plant otubains but they are thought to be
involved in many ubiquitin-related cellular processes (Aquea et al., 2008). An otubain
CysP, OTUBAIN-LIKE HISTONE DEUBIQUITINASE-1 in Arabidopsis, indicates its
role in transcriptional repression via histone deubiquitination (Krichevsky et al., 2011).
Otubain-like CysP was also discovered in pine and was found to be expressed during
early somatic embryogenesis of pine trees, but its biological function remains unknown
(Aquea et al., 2008).
The main physiological role of CysPs is metabolic degradation of peptides and
proteins. Mammalian CysPs have been associated with onset and development of many
diseases that involve abnormal protein turnover (Twyman et al., 2003). In plants, CysPs
play key roles in environmental stress response, nutrient remobilization and cellular
housekeeping, which account for nearly 30% of the proteolytic activity in mature tissues
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(Ueda et al., 2000). In Arabidopsis alone the genome codes for 32 papain-type CysPs,
which are classified into eight main groups based on their function and sequence
similarity to other known CysPs (Grudkowska and Zagdanska, 2004). These CysP groups
include, senescence- and stress induced- aleurain, mammalian cathepsin B-like, pineapple
bromelain-like, telo, KDEL and kiwi actinidain-like CysPs. The Arabidopsis CysPs are
known to carry out multifarious roles in different tissues and at different stages of plant
growth (Lee et al., 2004; Zhang et al., 2009). A highly senescence specific
SENESCENSE-ASSOCIATED GENES-12 was identified in Arabidopsis, which was
found to have an increasing expression during leaf senescence (Gan and Amasino, 1995).
Three different KDEL-type CysP, C-TERMINALLY ENCODED PEPTIDE (CEP)-1, 2
and 3 were also identified in Arabidopsis, and were found to be involved in the different
stages of plant growth (Gietl and Schmid, 2001). It was suggested that CEP2 could be
involved in developmental programmed cell death during the tracheary element
differentiation and cell elongation processes in the tissues. CEP1 and CEP3 were
expressed respectively in unpollinated ovules and mature siliques and represented
increase in CysP activity during the different developmental stages of plant. Some CysPs
in Arabidopsis have also been shown to be induced during biotic stresses. One of such
example is RESPONSIVE TO DEHYDRATION (RD) 19, which was induced during
infection with pathogenic bacteria Ralstona solanacearum, and was found to be involved
in disease resistance against the pathogen (Bernoux et al., 2008).
Though several CysPs have been characterized in Arabidopsis, not much is
known regarding the role of CysPs in tobacco. NICOTIANA TABACUM CYSTEINE
PROTEASE (NtCP) 23 is one of the earlier identified CysPs in tobacco and is involved
in amino acid remobilization in senescing leaves (Ueda et al., 2000). Few other tobacco
CysPs have also been characterized which are implicated in stress response, protein
degradation during programmed cell death (Zhao et al., 2013) and pollen grain
development (Zhang et al., 2009).
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Figure 1.2 Structure and substrate binding sites of papain A) Papain has two
structural domains with five alpha helices surrounding seven beta barrel sheets. The
active site is present the cleft between the two domains and consists of the catalytic triad
of Cys25, His159 and Asn175 residues (Grzonka et al., 2001). B) Substrate subsites of
papain. The substrate pocket is approximately 25 Å in length. The Letters Sn and S’n
represent subsites, where n=1, 2, 3, 4 and SH represents the sulfhydryl group. Pn
represents individual amino acid residues of the substrate that binds with the respective
subsites in papain (Schechter and Berger, 2012)
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1.8 Interleukin-10
Interleukin (IL)-10 is an immune-regulatory cytokine produced by immune cells
such as T cells, natural killer cells and macrophages. The role of IL-10 has been
investigated in the limitation and termination of immune responses during biological
therapy of different malignant, autoimmune and chronic inflammatory diseases
(Asadullah et al., 2003). IL-10 has been used as a model recombinant protein to study the
factors that control the synthesis and accumulation of recombinant proteins in plants
(Chen et al., 2013). For large scale production of IL-10, the low alkaloid variety of
tobacco-cv. 81V9 has been previously used (Menassa et al., 2001). Recombinant IL-10
was produced using stable expression in a higher amount than the transient expression
and was found to be biologically active during murine assays (Menassa et al., 2007). To
achieve higher levels of IL-10, subcellular targeting was utilized to accumulate IL-10 in
the ER by fusing ER retention signal KDEL to its C-terminal end. However, the
accumulation of IL-10 during initial stable expression is reported to be less than 1% of
the total soluble protein, a level which is not sufficient for the viable commercial
production of proteins. Some strategies have been applied to increase the yield of IL-10,
mostly through the tobacco cell-culture based system (Kaldis et al., 2013). However, as
stable protein expression can offers several advantages (as mentioned in section 1.3),
improving IL-10 accumulation in the stable transgenic tobacco line can serve as a better
source for production and supply of recombinant IL-10.
1.9 Hypothesis
Though tobacco allows high level production of recombinant proteins,
accumulation of IL-10 was lower than the critical level of 1% of total soluble protein in
stable tobacco lines. Since CysPs are known to degrade heterologously expressed
proteins in plants I hypothesize that tobacco CysP (s) affects IL-10 accumulation.
Altering specific CysP gene product(s) can minimize proteolytic degradation of IL-10
and increase its accumulation in tobacco leaves.
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1.10 Objectives
The whole genome sequence of tobacco is not available yet and only a few
tobacco CysP sequences have been reported. However, the availability of an expressed
sequence tag (EST) database of N. tabacum allows for the analysis of tobacco CysP
sequences that have been deposited by the researchers worldwide
(http://compbio.dfci.harvard.edu/cgi-bin/tgi/gimain.pl?gudb=tobacco). The database also
provides information regarding tissue specific expressions of different CysPs sequences.
The objectives of the present research are:
•

To identify all expressed CysP genes in tobacco.
This will be addressed by an extensive search for CysP genes in the tobacco EST
database and in silico analysis of predicted amino acid sequences for their domain
information.

•

To select candidate CysP genes that may have an effect on IL-10 accumulation.
Selection of CysPs will be done based on criteria such as expression in leaf tissue
and availability of full length sequences in the database. Expression levels of
candidate CysPs will be altered by RNAi silencing. The effect of RNAi silencing
of candidate CysPs on IL-10 accumulation will be compared in silenced lines and
controls.

•

To characterize IL-10 specific CysP gene(s).
Transient silencing and overexpression of CysP will be done to study the results
obtained from the stable CysP silenced lines. The potential site of IL-10
degradation will be studied by subcellular localization of candidate CysPs.
Because IL-10 was targeted to the ER, it is imperative to check the localization of
candidate CysP potential of degrading IL-10.
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Chapter 2: Materials and Methods
2.1 Plant materials and growth conditions
Seeds of tobacco (N. tabacum) cv. 81V9 and the transgenic line G7 (hereby called
as IL-10 control) were obtained from Dr. Rima Menassa (Agriculture and Agri-Food
Canada, London). The IL-10 control tobacco line overexpresses IL-10 and accumulates
in the ER (Menassa et al., 2001). The tobacco seeds were grown under sterile condition in
magenta boxes at 24°C and 16 h daylight for leaf disc transformation. For sterilization,
seeds were treated with 70% ethanol for 30 sec and air dried. Seeds were sown on
Murashige and Skoog (MS) basal medium (PhytoTechnology Laboratories, USA),
supplemented with 1% (w/v) phytoagar (PhytoTechnology Laboratories, USA), 4% (w/v)
sucrose (Sigma-Aldrich, Germany), phytohormones and the antibiotic, kanamycin (50
µg/ mL).
Transgenic tobacco plants were grown on PRO-MIX BX MYCORRHIZAETM soil
(Rivière-du-Loup, Canada) at 24°C, 60% relative humidity and 16 h daylight in the
greenhouse. For N. benthamiana, seeds were sprinkled into wet PRO-MIX BX
MYCORRHIZAETM soil (Rivière-du-Loup, Canada) and pots were covered with a
transparent plastic cover and grown at 25°C/ (day/night), 50% humidity and 16 h daylight
in the growth chamber. Two-week-old seedlings were transferred to new pots and
watered regularly. A nutrient mixture of nitrogen, phosphorus, and potassium (20-20-20)
was applied once a week for both types of tobacco plants grown in growth chamber and
greenhouse.
2.2 Bacterial strains
E. coli DH5α and DB3.1 strains (Invitrogen, USA) were used for cloning
purposes. For stable transformation in tobacco and transient infiltration in N.
benthamiana, Agrobacterium strain GV3101 was used. All bacterial transformations were
carried out by electroporation in a Gene Pulser® Cuvette (Bio-Rad Laboratories, Inc.,
USA) using MicroPulserTM (Bio-Rad Laboratories, Inc., USA). The electroporation was
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done for 6 millisec at an output voltage of 1.79 kV and 2.18 kV for DH5α and GV3101
respectively.
`2.3

In silico analysis
To identify CysP genes present in tobacco, the DFCI tobacco gene index

(http://compbio.dfci.harvard.edu/cgi-bin/tgi/gimain.pl?gudb=tobacco) was searched using
‘cysteine protease’ as keyword. This database contains ESTs obtained from cDNA
libraries constructed using different tissues or plants grown under different conditions or
exposed to different stresses. Complete and partial sequence availability of all putative
CysPs was checked using ExPASy software (http://web.expasy.org/translate/). Candidate
genes were selected according to their tissue-specific expression and availability of
complete sequences in the EST database. Predicted amino acid sequences of candidate
CysPs were aligned using CLUSTALW and the alignment file was exported to
BOXSHADE 3.21. The domain organizations of candidate CysPs were predicted using
Pfam 27.0 (http://pfam.xfam.org/). The subcellular localization of putative CysPs was
predicted using PSORT program (http://psort.hgc.jp/form.html).
2.4 Cloning
To clone CysP genes from tobacco, candidate genes were amplified by
polymerase chain reaction (PCR) using leaf cDNA as template and gene specific primers
which contained attB recombination sites. Primers and PCR conditions used for
amplifying CysP gene fragments for silencing and full open reading frames for
overexpression are shown in Table 2.1. All the primers contain th attB1 adaptor sequence
(5’-GGGG ACA AGT TTG TAC AAA AAA GCA GGC T-3’ for forward primers) and
the attB2 adapter sequence (5’-GGGG AC CAC TTT GTA CAA GAA AGC TGG GT-3’
for reverse primers), preceding their 5’sequences for cloning in gateway vectors.
2.4.1 Cloning for silencing constructs
To create CysP silencing constructs, a gene-specific region (178-345 base pairs)
for each candidate CysP was selected and amplified using gene-specific primers (Table
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2.1). The PCR products were separated on 1.5% agarose gels. A single band of CysP
amplicon was excised from the gel and purified using EZ-10 Spin Column DNA Gel
Extraction Kit (Bio Basic Inc., Canada). The purified gene fragments were recombined
into gateway entry vector pDONR/Zeo using the BP clonase reaction mix (Invitrogen,
USA), and the BP reaction products were transformed into E. coli DH5α by
electroporation. The transformed cells were grown in low salt Lysogeny Broth (LB) agar
containing 50 µg/mL of zeocin. Colonies that contained the recombinant plasmid
(pDONRZ-CysP) were screened using CysP gene specific primers. The positive E. coli
colonies that contained recombinant plasmid were picked and grown overnight in 3 mL
of LB at 370C. Plasmid DNA was extracted from overnight culture using EZ-10 Spin
Column Plasmid DNA Kit (Bio Basic Inc., Canada). The presence of CysP sequences in
the recombinant plasmids was verified by sequencing using vector-specific M13 forward
and reverse primers. After sequence verification, the pDONRZ-CysP plasmids were
recombined into RNAi destination vector pB7GWIWG2(II),0 or pK7GWIWG2D(II),0
using the LR clonase reaction mix (Invitrogen, USA). The destination vector
pB7GWIWG2(II),0 contains spectinomycin resistance gene for selection in bacteria, and
a Bar gene which confers herbicide BASTA resistance for the selection of transformed
plant cells (Figure 2.1A). Vector pK7GWIWG2.D contains kanamycin resistance for
selection in bacteria and an enhanced green fluorescent protein (eGFP) reporter gene,
which was used for visual screening of transgenic plants using UV fluorescent
microscope (Figure 2.1B).
The LR reaction products were transformed into E.coli DH5α by electroporation
and plated on a LB agar plate containing 50 µg/mL spectinomycin. A schematic
representation of BP and LR recombination is shown in figure 2.2A. After LR
recombination, positive E.coli colonies were screened using colony PCR with the primer
combination as shown in Figure 2.2B. The CysP fragments were inserted in the opposite
orientation after recombination with the destination vector. The orientation of each
candidate CysP gene in the destination vector was confirmed using a gene-specific
forward primer (CysPF) and the outward chloramphenicol resistance (Cmr) forward and
reverse primers (CmrF: 5’- CGA TTC AGG TTC ATC ATG CCG TCT-3’ and CmrR:
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5’-TGA GCA ACT GAC TGA AAT GCC TCC-3’). Positive E.coli colonies that
contained recombinant pK7GWIWG2D(II),0-CysP or pB7GWIWG2(II),0-CysP plasmids
were picked and grown overnight in 3 mL of LB at 37 0C. Plasmids DNA were extracted
from the overnight culture using EZ-10 Spin Column Plasmid DNA Kit. For the purpose
of introducing recombinant pK7GWIWG2D(II),0-CysP and pB7GWIWG2(II),0-CysP
plasmids into tobacco, the plasmids were transformed into Agrobacterium using
electroporation and grown in LB agar containing rifampicin (10 µg/mL), gentamycin (50
µg/mL ) and kanamycin (50 µg/mL for pK7GWIWG2D(II),0-CysP plasmids) or
spectonomycin (50 µg/mL for pB7GWIWG2(II),0-CysP plasmids).
2.4.2 Cloning of CysP genes for overexpression
To identify CysP genes that act on factor (s) which directly or indirectly influence
IL-10 accumulation, full-length coding regions of CysP genes were amplified using gene
specific primers (Table 2.1), purified using EZ-10 Spin Column DNA Gel Extraction Kit
(Bio Basic Inc., Canada) and recombined into pDONR/Zeo vector as described in section
2.4.1. Colonies that contain the pDONRZ-CysP plasmids were screened by PCR using
gene specific primers. Positive colonies that contained the right size of full length CysP
insert were selected and cultured overnight at 370C in LB medium containing zeocin (50
µg/mL). Plasmid preparation was done from the overnight culture using the EZ-10 Spin
Column Plasmid DNA Kit (Bio Basic Inc., Canada) and sequences were verified. After
sequence verification recombinant pDONRZ-CysP plasmids were recombined with
overexpression vector pB7WG2D,1 using the LR Clonase reaction mix and transformed
into E.coli DH5α (Invitrogen, USA). This destination vector contains a cauliflower
mosaic virus 35S promoter, which drives constitutive expression of CysP genes in the
plant and Bar gene for selection of transformed plant cells (Figure 2.1C). E.coli colonies
containing the recombinant plasmids (pB7WG2D,1-CysP) were screened using gene
specific primers by PCR. Positive colonies were cultured overnight at 370C in LB
medium containing spectinomycin (50 µg/mL).

21

Table 2.1: List of primers used for silencing and overexpression of CysPs.

Primer name

Sequence (5'-3')

Primer
annealing
temperature
(0C)

Amplicon
size (base
pairs)

52

280

52

242

52

178

60

280

Silencing
Primers
CysP1F

CCA CCA TAA ACA ATC ATC CAA TCC GT

CysP1-5R

TAC CTC TTC CCA TAC CTG TGA GC

CysP2F

TCC GTA CTT TTC TAG GAG CTT CAC

CysP2R

TGA CTA GTG TCA CAG TCG ACA AG

CysP3F

CAA CTC ATA GCT CCA CTC TCA CCA

CysP3R

TCC ATG TTC GAG TAG CCA TGA CTC

CysP4F

GGC TAG CTA GTG GTT CAT AAT GGC

CysP4R

CCA CGC CGA GTT TAT ACC CTT

CysP5F

ATC CCT TCC CCA CAT TCT CTG A

52

249

CysP6F1

GCG ATA CTT CCT ACA ATG ACG GTT G

54

345

CysP6R1

CAT CTC ACT ACC ATA TCC ACA GCA TCA

CysP7F1

CGT GGG ATA CTC TTC AGA TGA CTT GAC

52

204

CysP7R1

TCA GCA AAC TCA TTT AGA CCA AGC C

CysP8F1

GAA TGG AAA CAG AAG CAG GGG AAA G

53

281

CysP8R1

GGA GGA GCA TCA CAA TAA ACT GGA G

CysP 9F

GCA TGT GGC TGA TGC AGG A

50

255

CysP 9R

CGT GTT CTT CTA AGG GCA

CysP10F1

GTC CGT AAA ACC CAA AAC CAC AC

52

382

CysP10R1

GCT TCT CCA TCT CTC ATA CAA CTC C

51

1080

52

947

52

1087

52

1401

Overexpression
Primers
CysP1-OE-F

ATG TCT CGT TTC TCA CTC CTA TTG GC

CysP1-OE-R

GAA CGG AGC CCG AAT GCT GTT GTA

CysP2-OE-F

CGA GGA GCC TTG ACG AGA AAG ACA A

CysP2-OE-R

CTT AGA GTT CAT CCT TAG GTG CCG T

CysP5-OE-F

GTT CCA ATG TCT CGT TTC ACA CTC C

CysP5-OE-R

AGG CAA CGA CAG GGT AGG AT

CysP6-OE-F

GGC ATG GCA ACT CTT AGC TTT ACT C

CysP6-OE-R

TCA AGA ACT GCT CTT CTT TCC TCC
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B

C

Figure 2.1: Gateway silencing and overexpression vectors for use in plants. A)
RNAi silencing vector, pB7GWIWG2(II),0, B) RNAi silencing vector,
pK7GWIWG2D(II),0 and C) Overexpression vector, pB7WG2D,1. All the vectors
contain attR sites and a ccdb casettee for selection of successful recombination events.
Vector maps adapted and modified from: http://gateway.psb.ugent.be/search
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B

Figure 2.2: Cloning and screening strategy for CysP gene silencing. a) Schematic
illustration of gateway cloning for silencing of tobacco CysP genes. CysP PCR products
were cloned into entry vector pDONR/Zeo by BP recombination and RNAi silencing
vector pB7GWIWG(II),0 or pK7GWIWG2D(II),0 by LR recombination. CysP gene
fragments are placed in the opposite orientation after recombination event in the silencing
vector. b) Screening strategy for CysP gene inserts in RNAi vector. Gene specific
forward primer (CysPF) and chloramphenicol resistance forward and reverse primers
(CmrF and CmrR) are used to screen the double inserts of CysPs.
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Plasmid preparation was done from the overnight culture using EZ-10 Spin Column
Plasmid DNA Kit and transformed into Agrobacterium followed by plating in LB agar
containing rifampicin (10 µg/mL), gentamycin (50µg/mL) and spectinomycin (50
µg/mL). The Agrobacteria containing overexpression constructs were used for transient
infiltration in tobacco plants.
2.4.3 Cloning for subcellular localization
To study the localization of a candidate CysP, translational fusion was created
with a yellow fluorescent protein (YFP) using the gateway cloning method. Full-length
CysP6 excluding the stop codon was amplified by PCR and recombined to a gateway
entry vector pDONR/Zeo by the BP reaction (Invitrogen, USA). The reaction was used to
transform E.coli DH5α by electroporation and positive clones were screened using genespecific primers. Recombinant pDONRZ-CP6 plasmid was extracted from an overnight
culture grown in a 3 mL LB containing kanamycin (50 µg/ml) at 370C. The pDONRZCysP6 construct was sequenced using CysP6 sequencing primers and recombined with
the destination vector pEarlyGate101 to create a CysP6-YFP fusion using LR clonase.
The LR reaction product was transformed into E.coli DH5α using electroporation and
plated on the LB agar containing 50 µg/mL kanamycin, followed by screening using
CysP6 gene-specific primers. A positive E.coli colony containing recombinant plasmid
pEG101-CysP6-YFP plasmid was picked and grown overnight in a 3 mL LB at 370C.
Recombinant plasmid was extracted using EZ-10 Spin Column Plasmid DNA Kit and
transformed into Agrobacterium by electroporation.
A cyan fluorescent protein (CFP) targeted to localize in the ER was used as a
control to verify the probable localization of CP6-YFP in the ER. The control construct
was obtained from Arabidopsis Biological Resource Center (ABRC, clone name: ERCK) and contains an ER retention signal sequence fused to C-terminal region of CFP
(Nelson et al., 2007).
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2.5 Tobacco transformations
2.5.1 Stable transformation and generation of transgenic lines
To generate stable tobacco transgenic lines, the CysP silencing constructs were
introduced into leaf cells by Agrobacterium mediated transformation. Agrobacterium
with CysP silencing construct (as obtained in section 2.4.1) was grown in 3 mL of
infiltration culture medium containing 10 mM morpholino-ethanesulfonic acid [MES] pH
5.6, 100 μM acetosyringone supplemented with rifampicin (10 µg/mL), gentamycin (50
µg/mL) and kanamycin (50 µg/mL for pK7GWIWG2D(II),0-CysP) and spectinomycin
(50 µg/mL for pB7GWIWG2(II),0-CysP ). The 3 mL culture was grown overnight at 28
0

C and transferred to a fresh 40 mL infiltration culture medium later. The culture was

allowed to grow at 28 0C until it reached an optical density (OD600) of 0.5-0.8. After the
optimum OD was obtained, the culture was transferred to a 50 mL conical tube and
centrifuged at 3000g for 30 min. The pellet was resuspended in Gamborg’s solution (3.2
g/L Gamborg’s B5 and vitamins, 20 g/L sucrose, 10 mM MES pH 5.6, and 200 μM
acetosyringone) to a final OD600 of 1 and incubated at room temperature for 2h with
gentle agitation to activate the virulence gene required for transformation.
Transformation of tobacco leaves was performed using the leaf disc
transformation method in a sterile laminar flow hood. Five mm2 tobacco leaf explants
were submerged in Agrobacterium suspensions, briefly dried on a filter paper, and placed
on plates containing MS medium supplemented with naphthalene acetic acid (NAA- 1
mg/L) and benzyl aminopurine (98 μg/L) (MST-agar medium). After 2-3 days of coculture with Agrobacterium, the leaf explants were transferred to a new MST-agar
medium containing Timentin (500 mg/L) and BASTA (4 mg/L). Timentin helps to kill
live Agrobacterium cells after the transformation. The explants were then transferred to a
BASTA only MST medium after 3 days and the medium was changed every week until
calli developed from the transformed plant cells. The regenerated calli differentiated into
independent shoots, which were cut and transferred to a rooting MST-agar medium after
6 weeks. The rooting medium was supplemented with NAA (1 mg/L) only. CysP
silenced shoots were transferred to the soil after sufficient roots were grown in the
26

rooting medium. Individual lines were grown in different pots and transferred to the
greenhouse. The plants were grown together with IL-10 control plants and used for the
evaluation of IL-10 levels.
2.5.2 Transient expression
To study the subcellular localization of CysP6 and the effect of overexpressing
some CysPs on IL-10 accumulation, transient transformation was used. For the
subcellular localization study, 4-6 weeks old tobacco leaves (tobacco, in this case means
N. benthamiana) were infiltrated with the transformed Agrobacterium suspension culture
as described in the section 2.5.1. For co-localization with the ER control, Agrobacterium
cultures containing pEG101-CP6-YFP and pEG101-ERCFP constructs were mixed in a
ratio of 1:1 and co-infiltrated in the tobacco leaves. Infiltration was done using a 1 mL
needle-less syringe by pressing the plunger against the lower leaf epidermis. The plant
was left at room temperature and the subcellular localization was visualized after 48 h
using confocal microscopy.
For the transient overexpression of CysPs, Agrobacterium cells containing the
CysP overexpression constructs were infiltrated into tobacco, as described in section
2.5.1 for the transfer of transgenes into plant, and with the help of needle-less syringes.
The tissues were collected 4 days post infiltration in order to analyze the effects on IL-10
accumulation levels.
2.6 Confocal Microscopy
Transient expression of CP6-YFP and CFP-KDEL was visualized using a Leica
TCS SP2 inverted microscope. A 63X water immersion objective lens was used at an
excitation wavelength of 514 nm for YFP and 434 nm for CFP. The emission
wavelengths for YFP and CFP were between 530-560 nm and 460-490 nm, respectively.
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2.7 Sample collection for protein and RNA extractions
Leaf tissues were sampled when tobacco plants reached a height of ~1.5 ft. Six to
eight leaf discs were taken from the 3rd, 4th and 5th leaves from the top. Leaf tissues were
collected in 2 mL Eppendorf tubes that contained 2 small copper beads (BioSpec
Products Inc, USA). Once the leaf samples were collected and the weight recorded, they
were immediately frozen in liquid N2 and stored at -80 0C freezer.
2.8 Protein extraction
For protein extraction, tubes containing leaf samples were placed in precooled
homogenization blocks, and homogenized using a mixer mill at 25 Hertz for 1 min.
Protein extraction buffer (400 µL) containing 1X Phosphate buffer saline (PBS, pH 7.4),
0.1% TWEEN-20, 1mM EDTA, 100 mM sodium ascorbate, 2% PVPP, 1 mM PMSF and
100 µg leupeptin was added to the homogenized tissue. PVPP is insoluble in water, hence
required at least 2-4 h of hydration before use. The lysates were centrifuged at 14,000 g at
40C for 10 min in a microcentrifuge, and the supernatants were collected.
2.9 Protein assay
Total soluble protein was measured using the Bradford dye reagent (Bio-Rad
Laboratories, Inc., USA). Protein assays were carried out according to Bradford’s method
(Bradford, 1976). Bovine serum albumin (BSA) solutions of concentrations 0, 40, 100,
200, 400, 600 and 800 µg/mL were used for creating a standard curve. Standards and the
TSP samples (10 µL each) were added to a 96-well plate, and 200 µL of Bradford dye
(diluted 1:5 in ultrapure water) was added to each sample. The absorbance was measured
at 595 nm after 30 sec using a BioTek Synergy2 microplate reader (BioTek Instruments,
Inc., USA). Three technical replicates were used for each sample and standard. The
absorbance of the BSA standards was plotted against their concentrations to generate a
standard curve whose linear range was used to determine the concentrations of proteins in
unknown samples. The extraction buffer was used as blank to subtract the background.
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2.10 Enzyme-linked immunosorbent assay (ELISA)
To measure IL-10 levels in CysP silenced and overexpressed tobacco lines,
ELISA was used. An enhanced protein binding ELISA plate (Nunc-Immuno, Maxi-Sorp
plates, VWR International, USA) was coated with 100 ng of purified rat anti-human IL10 capture antibody per well and incubated at 40C overnight. The antibody was diluted in
in 0.1 M Na2HPO4 pH 9.0. Following the incubation, the plate was washed two to three
times with wash buffer (PBS and 0.05% (v/v) Tween-20) and saturated with 200 µL of
blocking buffer (1% BSA in PBS) to avoid non-specific binding in the wells.
The extracted protein samples were diluted by 10 times in the blocking buffer and
100 µL of diluted samples were added to each well of the capture antibody-coated ELISA
plate. Pure protein for human IL-10 (BD Pharmingen, Canada) was used as the standard
at the concentrations of 2, 1, 0.5, 0.25, 0.125 and 0.0625 ng/mL. Once the standards (10
µL) and samples were loaded, the plate was incubated at room temperature for 4 h and
then washed two to three times with the wash buffer. Three technical replicates were used
for all samples and standards. Following the wash, biotinylated anti-IL-10 antibody (BD
Pharmingen, Canada, 100 ng/well; 100 µl of 0.5 µg/ml diluted antibody solution in
blocking buffer) was added to each well using multichannel pipette. The plate was
incubated for 1 h at room temperature with gentle shaking, followed by three washes with
the wash buffer. After the wash, secondary antibody conjugated to Horse Radish
Peroxidase (HRP) (BD Pharmingen, Canada, 100 ng/well diluted in blocking buffer) was
added to each well. The plate was kept at room temperature for 30 min followed by four
washes with the wash buffer before adding the substrate. Hundred microliter of 2,2'azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS dissolved in 300 ng/mL of
0.1M citric acid) containing 30% H2O2 was added to each well, incubated at room
temperature for 3.5 min, and the absorbance was measured at 405 nm using microplate
reader (Bio TeK Instruments, Inc., USA). The absorbance of blocking buffer was used as
blank. IL-10 standard curve was generated by plotting absorbances of the standards
against their respective concentration and the graph was used to determine IL-10 level in
the unknown samples.
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2.11 Genomic DNA extraction and genotyping of T1 transgenic lines
To screen transgenic lines, T1 seeds obtained from the CysP silenced T0 tobacco
lines were grown in MST-agar containing BASTA (4 mg/L). The BASTA resistant
seedlings were transferred to small pots. Seedlings were grown for 2 weeks and leaf
tissue was sampled from each independent transgenic line for genomic DNA extraction.
Genomic DNA was extracted from tobacco leaves using the cetyltrimethylammonium bromide (CTAB) method (Stewart and Via, 1993). Approximately
5 to 8 leaf discs were lysed in a 2 mL microfuge tube using 500 μL of extraction buffer
(1.4 M NaCl, 2% [w/v] CTAB, 50 mM Tris-HCl pH 8.0, 10 mM EDTA and 0.1 mg/mL
RNase added just prior to use) and incubated at 650C for 20 min. The samples were
allowed to cool down to room temperature and 500 μL of chloroform was added. The
mixtures were vortexed thoroughly and centrifuged for 3 min at 14000 g. The aqueous
upper phase was transferred to a clean microfuge tube to which 0.6 volume of
isopropanol was added and mixed thoroughly by vortexing. The samples were then
centrifuged for 10 min at 14000 g, and the pellets washed with 1 mL 70% (w/v) ethanol.
The pellets were air dried and dissolved in 20-50 μL of sterile MilliQ water.
Genotyping was carried out to identify transgenic T1 plants using genomic DNA
as template and chloramphenicol resistance primers CmrFw: 5’GGAGGCATTTCAGTCAGTTGCTCA- 3’ and CmrRv: 5’AGACGGCATGATGAACCTGAATCG-3’ (Figure 2.1A).
2.12 RNA isolation and RT-PCR analysis
To check silencing or overexpression of CysPs in tobacco, total RNA was
extracted from tobacco leaves using a RNeasy Plant Minikit (Qiagen Inc., USA)
following manufacturer’s instructions with slight modifications. On column DNase1
(RQ1 RNase-Free DNase, Promega, USA) digestion was performed in order to get rid of
the any genomic DNA contamination during extraction. RNA was quantified using a
NanoDrop spectrophotometer (Thermo SCIENTIFIC, USA). The integrity of RNA was
checked by running 300-500 ng of RNA on 1.2% (w/v) agarose gel in 1X TAE buffer (40
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mM Tris, 40 mM acetate, 1 mM EDTA, pH 8.2). cDNA was synthesized from 1 μg of
RNA using a QuantiTect® Reverse transcription Kit (Qiagen Inc., USA). To check the
transcript level of CysP6 in transient silencing or overexpression experiments, gene
specific primers (Table 2.1, CysP6-OE-F/R) were used for 36 cycles of PCR. Ten
microliters of amplified product was run on a 1.5% agarose gel.
A quantitative RT-PCR (qRT-PCR) was performed to evaluate the level of CysP6
in T1 stable CysP6 silenced plants. For this procedure, SsoFastTM EvaGreen® Supermix
(Bio-Rad Laboratories, Inc., USA) was used with CFX96 real-time PCR detection system
(Bio-Rad Laboratories, Inc., USA). CysP6 transcript accumulation was checked using the
following primers, qCP6F: 5’- CACCATATCCCTACTTCTCCTCCTC -3’ and qCP6R:
5’- CCATGTTCGACTAGCCATGACTC-3’. The amplicon was cloned into pGEMT
vector (Promega, USA) and its sequence was verified. N. tabacum Actin (NtActin, Gene
bank ID: AB158612.1) was used as a reference gene. The primers used for reference gene
amplification were, qNTActinF: 5’-GGTTGGTATGGGTCAAAAGGATCA-3’ and
qNTActinR: 5’-GGAGCAACACGCAACTCATTG-3’. The melting curve analysis was
performed with pDONR-CysP6 plasmid as a template.
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Chapter 3: Results
3.1 Tobacco genome contains at least 60 putative CysPs
To identify CysP genes in tobacco, an in silico search was done using the DFCI
tobacco gene index (TGI) database. The TGI consists of 324,058 ESTs. A total of 55
putative CysP genes were identified by the keyword search ‘cysteine protease’. Out of 55
putative CysP gene sequences, 32 were tentative contig sequences which were created by
assembling ESTs into virtual transcripts. The rest were 23 singleton sequences, each of
which represented a unique EST in the database. These putative CysPs were derived from
tobacco cDNA libraries constructed from a variety of tissues including leaf, flower, root,
whole seeding or cultured tobacco (cv Bright Yellow, BY-2) cells. Table 3.1 provides a
list of putative CysP genes as represented by their tentative contig or singleton sequence
identification numbers, tissue specific expressions and predicted protein sizes for those
where complete coding regions were available. Of the 55 putative CysP genes, 10 genes
were selected as candidates for further study based on complete sequence availability and
expression in leaf tissue. Leaf specific CysPs were of main interest, as the principal
objective of this research was to identify potential CysPs involved in determining IL-10
yield in leaf. The candidate CysPs were named as CysP1 to CysP10.
In addition to the 55 putative CysPs identified through a database search, five other
CysP sequences were found through a literature search. Their accession numbers and the
paralog tentative contig sequences are shown in Table 3.2. Among them, NtCP1 was
expressed only in senescing leaves and NtCP2 was expressed in mature tobacco leaves.
NtCP56 was strongly expressed in anthers. CyP7 and CyP8 were expressed in leaf
tissues. A very high degree of amino acid identity was found between NtCP56 and
CysP10 (99.17%), which indicates that they might perform similar functions in tobacco.
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Table 3.1 List of putative CysP genes in tobacco.

a

TC
sequence

Most
expressed
ina

Candidate
CysP

Predicted
Protein
size (AA)b

Singleton
Sequence

TC122594

R,L

CysP1
(NtCP23)

360

BP132783

BY-2

_

TC123875
TC124565
TC124614
TC124631
TC126531
TC128311
TC129167
TC129618
TC130400
TC130996
TC132948
TC133645
TC133786
TC135985
TC139681
TC140530
TC141516
TC143494
TC143787
TC144748
TC145665
TC151953
TC152484
TC154564
TC155175
TC162422
TC163159
TC164523
TC164665
TC166013
TC166795

R
L,F,R
R,L
L,F,R
L,F,R
L,F,R
L,F,R
L,F,R, BY-2
R
L,F,R
L,F,R
L,F,R
BY-2
L,R
L,F,R
L,R,W
L,F,R
L,F,R
L,F,R
L, R,W
L,R
W
L,F,R,W
L,R
L,F,R,W
L
L,W
L
L,F,R
Proembryo
L,F,R

_
240
_
_
_
_
_
360
_
_
466
349
_
_
_
_
355
434
301
_
_
_
_
_
_
_
_
_
_
_
361

BP529990
CN498801
DV159633
DW001815
AM837057
AM829003
AM831937
AM791536
AM787277
AM846161
AM834885
AM836936
AM801664
AM787303
AM823454
AM801795
AM844688
FG634183
FG644916
FG167001
FG172560
FG190220

BY-2
L
Seed
L,R
L
L
L
L
L
W
W
W
L
W
W
W
W
L
L
R
R
L,F,R

_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_

CysP2

CysP3

CysP5

CysP6 (NtCP6)
CysP4

CysP7
CysP8
CysP9

CysP10

Most
Predicted
expressed Protein
in
size (AA)b

L, leaf; F, flower; R, root; W, whole plant, BY-2, Nicotiana tabacum cv. Bright Yellow

cell line; bAA, amino acid; -, partial CysP sequences
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Table 3.2 Comparison of published tobacco CysP sequences with tentative contig
sequences from tobacco EST database.

a

CysP
genes

Accession #

Closest tentative
contiga

Amino Acid
identity (%)

Reference

NtCP1

AY881011

TC133645 (CysP4)

94.84

(Beyene et al., 2006)

NtCP2

AY881010.1

TC124565 (CysP2)

96.6

(Beyene et al., 2006)

CyP7

Z13959.1

TC131927

97.8

(Linthorst et al., 1993)

CyP8

Z13964.1

TC131927

97.5

(Linthorst et al., 1993)

NtCP56

EU429306.1

TC166795 (CysP10)

99.17

(Zhang et al., 2009)

highlighted tentative contigs, candidate CysPs
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3.2. Catalytic triad and non-contigious ERFNIN motif are conserved in candidate
CysPs
CysP1- CysP8 and CysP10 have a common papain domain that has been shown to be
responsible for endo and exo-peptidase activity of CysPs. Proteins containing such
domains are classified under the papain or peptidase_C1 family and are synthesized as
precursor CysPs (Wiederanders et al., 2003) .
Precursor CysPs have an additional propeptide sequence preceeding their papain
domain. As shown in Figure 3.1, all of these CysPs have a propeptide sequence which is
also called as I29 or the cathepsin propeptide inhibitor domain. For enzyme activation,
papain family CysPs require a cleavage of the propeptide sequence (Wiederanders et al.,
2003). CysP6 and CysP8 have an additional granulin-like repeat that is known to play a
role in targeting and activity regulation of certain CysPs (Tolkatchev et al., 2001). CysP9
may belong to the otubain or peptidase_C65 family since it consists of a single large
Ovarian Tumor (OTU) domain, and may have similar functions to that of
deubiquitinating enzymes of the peptidase_C65 family. Detailed information regarding
putative domain lengths of all candidate CysPs is shown in detail in Table 3.3.
To identify catalytic residues in the CysPs, the deduced amino acid sequences of
those belonging to the papain family were aligned, along with a previously characterized
tobacco CysP, NtCP23 (Figure 3.2). A catalytic triad comprised of Cys25, His159 and
Asn175 (papain numbering) was found in the papain domain of all aligned CysPs. The
catalytic site of these CysPs is a thiolate-imidazolium ion pair between Cys25 and
His159, which forms a reactive cysteine nucleophile (Grzonka et al., 2001). The
alignment shown in Figure 3.2 excludes CysP3 as it lacked several N-terminal amino acid
residues, and critical residues Asn and His in the catalytic triad. A highly conserved block
of amino acid interspersed with variable residues, EX3RX3FX2NX3I/VX3N (ERFNIN
motif), is present in the propeptide region of all papain family CysPs (Karrer et al., 1993).
The candidate sequence alignment also revealed such general features in the papain
family CysPs (Figure 3.2).
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CysP1, CysP2, CysP4,
Cysp5, CysP6, CysP7,
CysP8, CysP10

CysP6, CysP8

CysP9

Figure 3.1: Schematic representation of different domains in papain family tobacco
CysPs. Candidate CysPs having specific domain types are indicated on the right side. The
diagram is not drawn to scale. I29, cathepsin propeptide inhibitor domain; Peptidase_C1,
papain family domain; GRN, granulin like repeats; Peptidase_C65, otubain family
domain
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Table 3.3 Detail domain information of the candidate CysPs.

Candidate CysPs

Cathepsin
propeptide
inhibitor domain

Papain family
CysP domain

Granulin
like
repeats

Otubain
domain

CysP1(NtCP23)

61-117

143-358

X

X

CysP2

Cleaved

5-221

X

X

CysP3

53-110

141-246*

X

X

CysP4

42-99

131-348

X

X

CysP5

61-117

143-358

X

X

CysP6(NtCP6)

50-107

138-353

387-435

X

CysP7

49-105

137-352

X

X

CysP8

1-41

75-292

339-387

X

CysP9

X

X

X

45-300

CysP10

38-93

126-342

X

X

Numbers in the domains represent amino acids.
*complete coding region sequence was not available.
X, absent in respective CysPs.
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CysP2
CysP10
CysP7
CysP4
CysP8
NtCP6
NtCP23
CysP5

----------------------------------------------------------------------------------------------------------MKKLLLLLFALALVLRLGES-----FDFHEKELETEEKLWELYERWRSHH-TVSRSLDEKDKRFNVFKANV
------------MAIFSISKLSLLVLFSISLLACTSFARDHSIVGYSSDDLTCIDKLINLFEHWMDKHGKIYKSIEEKLHRFEIFKDNL
------------MAFANLSQYLCLALFFIFLGVWRSQV-------ASSRPINYEASMRARHDQWIAHHDKVYKDLNEKEMRFKIFKENV
-------------------------------------------------------------------------------MRLEKFRRNV
--------MATLSFTLTIS---LLLLLFLFFSTLSSASDMSILTYDENQHFRTDDEVMSLYESWLVEHGKSYNALDEKDKRFQIFKENL
MSRFSLLLALVVAGGLFASALAGPATFADENPIRQVVSDGLHELENAILQVVGKTRHALSFARFAHRYGKRYESVEEIKQRFEVFLDNL
MSRFTLLLALVVAGGLFAAALAGPATFAVENPIRQVVSDGLHELENGILQVVGQSRHALSFVRFAHRYGKRYESVEEIKQRFEVFLDNL

CysP2
CysP10
CysP7
CysP4
CysP8
NtCP6
NtCP23
CysP5

----------------------------------------------------------- MRIDVPPTVDWRKKGAVTPVKDQGKCGSC
HYVHNFNK---KDKPYKLKLNKFADMTNHEFRHHYAG-SKIKHHRTFLGASRANGTFMYAHEDSVPPTVDWRKKGAVTPVKDQGKCGSC
KHIDETNK---IVSNYWLGLNEFADLSHDEFKKMYLG-LKVDN-ELLNKREKSQQEFAYRDFVDLPKSVDWRKKGAVTPVKNQGQCGSC
ERIEAFNAG--EDKGYKLGVNKFSDLTNEKFRVLHTG-YKRSHPKVMSS-SKPKTHFRYANVTDIPPTMDWRKKGAVTPIKDQKECGCC
KYIVEKNSKRKSDSDHLVGLTNFADMSNEEFRQVHTSKIKIPFDKRKTIQMKNAEKKPTPVYCDAPPSRDWRKHGAVTEVKNQHLCGAC
RYIDEQNS--VPNKSYKLGLTKFADLTNEEYRSMYLG-TKTSDRRRLLK--NKSDRYLPKVGDSLPDSVDWREKGVLVGVKDQGSCGSC
KMIRSHNK---KGLSYKLGVNEFTDLTWDEFRRDRLG--------AAQNCSATTKGNLKVTNVVLPETKDWREAGIVSPVKNQGKCGSC
KMIRSHNK---KGLSYKLGVNEFTDLTWDEFRRDRLG--------AAQNCSATTKGNVKLTNAVLPETKDWREDGIVSPVKNQGKCGSC

CysP2
CysP10
CysP7
CysP4
CysP8
NtCP6
NtCP23
CysP5

WAFSTVVAVEGINQIKTNELVSLSEQELVDCDTS-QNQGCNGGLMDMAFEFIKKKGGINTEENYPYMAEGGECDIQKRNSPVVSIDGHE
WAFSTVVAVEGTNQIKTNELVPLSEQELVDCDTS-QNQGCNGGLMDMAFEFIKKKGGINTEENYPYMAEGGECDIQKRNSPVVSIDGHE
WAFSTVAAVEGINQIKTGNLTSLSEQELIDCDTT-YNNGCNGGLMDYAFQFIISNGGLHKEDDYPYLMEEGTCDEKRDESEVVTIDGYH
WAFSAVAATEGLHQLKTGKLIPLSEQELVDCDVEGEDEGCSGGLLDTAFDFILKNKGLTTEANYPYKGEDGVCNKKKSALSAAKIAGYE
WAFSACGAMEGINAIVTGEIISLSVQQLINCDNS-TNLGCYGGYMDPAFEWVMNNSGIDSDSDYPYTVSQGACNITKVNQKVVTIDGYR
WAFSAIASVEAVNSIVTGDVISLSEQELVDCDTS-YNDGCNGGLMDYAFDFIIKNGGIDTEEDYPYTGRDGRCDQSRKNAKVVTINGYE
WTFSTTGALEAAYSQAFGKGISLSEQQLVDCAGAFNNFGCNGGLPSQAFEYIKSNGGLDTEEAYPYTGKNGLCKFSSENVGVKVIDSVN
WTFSTTGALEAAYSQAFGKGISLSEQQLVDCAGAFNNFGCNGGLPSQAFEYIKSNGGLDTEEAYPYTGKNGLCKFSSENVGVKVIDSVN

CysP2
CysP10
CysP7
CysP4
CysP8
NtCP6
NtCP23
CysP5

DVPPNDEGSLLKAVANQPVSVAIQASGSDFQFYSEGVFTG-DCGT---ELDHGVAIVGYGTTLDRTKYWIVKNSWGPEWGEKGYIRMQR
DVPPNDEGSLLKAVANQPVSVAIQASGSDFQFYSEGVFTG-DCGT---ELDHGVAIVGYGTTLDRTKYWIVRNSWGPEWGEKGYIRMQR
DVPANDEQSLLKALANQPLSVAIEASGRDFQFYSGGVFDG-HCGT---ELDHGVAAVGYGTTKG-ADYIIVKNSWGPKWGEKGFIRMKR
DVPANSEKALLQAVANQPVSVAIDGSSFDFQFYSSGVFSG-SCST---WLNHAVTAVGYGATTDGTKYWIIKNSWGSKWGDSGYMRIKR
DVP-QEESALLCAVAQQPVSAGIDGASADFQLYRGGIYDG-SCSSNPDDLSHGVLIVGYGSAGD-DDYWIIKNSWGTSWGMEGYGYIRR
DVPENNEKALQKAVASQPVSIAIEAGGKDFQHYVSGIFTG-KCGT---AVDHGVVAVGYGSENG-MDYWIIRNSWGASWGEKGYLRVQR
ITLGAEDELKYAVALVRPVSIAFEVIKG-FKQYKSGVYTSTECGNTPMDVNHAVLAVGYGVENG-VPYWLIKNSWGADWGDNGYFKMEM
ITLGAEDELKYAVALVRPVSIAFEVIKG-FKQYKSGVYSSTECGNTPMDVNHAVLAVGYGVENG-VPYWLIKNSWGADWGDDGYFKMEM

202
323
333
329
273
334
343
343

CysP2
CysP10
CysP7
CysP4
CysP8
NtCP6
NtCP23
CysP5

EIDAEEGLCGIAMQPSYPIKTSSSNPTGSPATAPKDEL--------------------------------------------------EIDAEEGLCGIAMQPSYPIKTSSSNPTGSPATAPKDEL--------------------------------------------------NTGKAEGKCGINKMVSFPVKKK------------------------------------------------------------------DVHEKEGLCGLAMDASYPTA--------------------------------------------------------------------NTDLPYGVCAINSLASYPTKELASAPSPYPSPAVPPPPSPSPPPPQPPSPKPSECGNLYYCPEDQTCCCELEFFGICVIQSCCPHKNGV
NVASSKGLCGLAIEPSYPVKTGVNPPKPSPSPPSPIKP-------------PTQCDDYAQCPEGTTCCCVFEYYNSCFSWGCCPLEGAT
GKN----MCGIATCASYPVVA-------------------------------------------------------------------GKN----MCGIATCASYPVVA--------------------------------------------------------------------

240
361
355
349
362
410
360
360

65
77
70
10
78
89
89

* *

*

29
150
161
155
99
162
167
167

*

*

*

117
238
249
244
187
250
256
256

*

Figure 3.2: Multiple sequence alignment of papain family CysPs. Predicted amino
acid sequences of NtCP23 (CysP1), CysP2, CysP4, CysP5, NtCP6 (CysP6), CysP7,
CysP8 and CysP10 were aligned using CLUSTALW and shaded using BOXSHADE
3.21. Identical and conserved amino acids are shaded in dark and light grey, respectively.
(*) indicates catalytic residues cysteine (C), histidine (H) and asparagine (N). (*)
indicates the disulfide bridge-forming cysteine residues. Red box indicate endoplasmic
reticulum retention signal KDEL in CysP2 and CysP10. The conserved ERFNIN motif in
the propeptide region is double-underlined.
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3.3 Generation of candidate CysP RNAi constructs
To identify CysPs that influence IL-10 accumulation in tobacco, RNAi silencing of
selected CysPs was performed. Candidate genes CysP1 to CysP5 were cloned into RNAi
vector, pK7GWIWG2D(II),0 and CysP6 to CysP10 in pB7GWIWG(II),0 as described in
section 2.4.1 and Figure 2.2A. Gene specific unique sequences were cloned in opposite
orientation in the destination vector to create RNAi constructs. The RNAi constructs are
transcribed to the hairpin RNA precursors which are processed into the small interfering
RNA’s (siRNA) by the homologues of the enzyme dicer and incorporated into RNAinduced silencing complex (RISC). Silencing is achieved either by sequence specific
degradation of complementary target sequences or by repression of CysP messenger
RNA by the RISC (Meister and Tuschl, 2004).
Unique regions were identified for each of the CysP sequences to facilitate targeted
gene silencing. RNAi vectors with the specific CysP inserts were screened using two
different primer combinations by PCR, which gave the amplicons of different sizes as
shown in Figure 3.3. The first amplicon was produced by the gene specific CysP forward
primer (CysPF) and Cmr forward primer (CmrF), and contained the larger intron (In-1,
376 bp) region. The second amplicon was produced by CysPF and the Cmr reverse
primer (CmrR), and contained the smaller intron (In-2, 275 bp) region. The silencing
constructs were transformed into Agrobacterium in-order to deliver them into tobacco
leaf epidermal cells.
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Figure 3.3: Strategy for CysP silencing. Screening of CysP double inserts in the
silencing vector. Primer combinations used for screening are shown by arrowheads in the
RNAi construct. Gene specific forward primers (CysPF) and chloramphenicol resistance
forward and reverse primers (CmrF and CmrR) produce the CysP amplicons of specific
sizes. Agarose gel images demonstrate the amplicon size differences for specific CysP
inserts. The numbers on the top of each lane correspond to the amplicon size.
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3.4 RNAi silencing of candidate CysP genes and generation of stable CysP silenced
tobacco lines
To generate CysP silenced tobacco lines, Agrobacterium cultures harbouring CysP
RNAi constructs were used to transform tobacco G7 line. The G7 line is a useful control
for this experiment as in the untransformed state it constitutively overexpresses IL-10.
Figure 3.4 describes the process of generating CysP silenced tobacco plants using leaf
disc transformation and the approximate time it required to proceed from one stage to the
other. The leaf disc and Agrobacterium were co-cultured for 2-3 days and transferred to
callus induction medium containing herbicide BASTA for selection. After nearly 1.5
weeks, calli were induced from the transformed tobacco cells, leaving the untransformed
cells dead in the tissue culture medium. The induced calli were transferred to the
differentiation medium where they gave rise to small shoots in 4-6 weeks. A single shoot
was cut from individual callus and transferred to a new plate which later giving rise to an
independent transgenic line. In approximately 16 weeks from the initial transformation,
the independent transgenic lines were ready for an evaluation of CysP transcript and IL10 levels.
In addition to the targeted silencing of specific candidate CysPs, a conserved region
of CysP1 to CysP5 genes was also chosen for silencing and two silenced lines (CysPAllSi) were generated. A total of 82 CysP silenced T0 lines were generated for all candidate
genes (Table 3.4). Since no RNAi line could be generated for CysP5, further work on that
candidate gene was not carried out.
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L-10 Control

16 weeks: T0 plants in greenhouse

Day 1: Co-culture
9 weeks: root induction

1.5 weeks: callus induction

4 weeks: callus differentiation

6 weeks: CysP silenced
tobacco plantlets

Figure 3.4: Generation of stable CysP silenced tobacco lines. G7 tobacco lines
overexpressing IL-10 protein were grown in magenta boxes. Leaf discs were cut and cocultured with Agrobacterium cultures containing candidate CysP silencing constructs.
Calli were regenerated from transformed cells and subcultured in differentiation medium
containing BASTA (4 mg/L). Independent CysP silenced transgenic lines were obtained
from the individual callus and transferred to the rooting media before transferring them to
greenhouse.
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Table 3.4: Numbers of independent CysP silenced T0 tobacco lines.

Candidate CysP
gene

CysP silenced
lines (T0)

Candidate CysP
gene

CysP silenced
lines (T0)

CysP1

11

CysP6

16

CysP2

6

CysP7

9

CysP3

8

CysP8

9

CysP4

5

CysP9

12

CysPAll-Si

2

CysP10

4
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3.5 Silencing of CysP6 increases IL-10 accumulation in independent T0 tobacco lines
To determine the effect of CysP silencing in the accumulation of recombinant IL10, the IL-10 levels were measured using a double sandwich (dsELISA) in T0 tobacco
lines, all of which were generated from the independent transformation events. The
principle of dsELISA is shown in Figure 3.5. The dsELISA results revealed that IL-10
levels were higher in six out of thirteen CysP6 silenced lines compared to the controls
(Figure 3.6). Three other lines measured for IL-10 (CysP6Si-4, 7 and 13) displayed
almost similar levels of IL-10 accumulation in comparison to the control. IL-10 level was
increased by nearly 1.6- fold in CysP6Si-15, the highest IL-10 accumulating line. Results
indicate that silencing of CysP6 can affect IL-10 accumulation in T0 lines of G7 tobacco.
IL-10 accumulation levels were also checked for CysP1, CysP2, CysP3, CysP4,
CysP7, CysP8, CysP9 and CysP10 silenced independent T0 lines. As shown in Figure 3.7,
there was no increase in IL-10 accumulation among any of these lines when compared to
the levels in IL-10 control plants except, for CysP8 silenced line (CysP8Si-3). These
CysP silenced lines were generated over different periods of time. Therefore, for an
appropriate comparison between the IL-10 levels, IL-10 control plants were also grown at
the same time with CysP silenced plants. The accumulation of IL-10 varied among the
control plants, even though the plants were grown under similar conditions. Thus, IL-10
accumulations for different T0 lines are represented as normalized fold levels. The
normalized fold levels are the ratios of IL-10 levels present in the silenced lines to the
levels present in the IL-10 control plants.
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Figure 3.5: Detection of IL-10 by dsELISA. A) Schematic illustration of IL-10
quantification. The 96-well ELISA plate was coated with anti- IL-10 capture antibody
and 0- 2 ng/ml of IL-10 standard was added. Primary and secondary antibodies were
added allowing triplicate determination to be made in each channel. B) Standard curve
for the IL-10 concentration versus luminescence intensity (OD405). Luminescence
increased in concentration dependent fashion.
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Figure 3.6: IL-10 accumulation in CysP6 silenced T0 tobacco lines. Measurement of
IL-10 level in independent T0 CysP6 silenced lines by dsELISA. Data label above the bar
represents IL-10 level of individual CysP6 silenced lines expressed as ng/mg of total
soluble protein. + indicates the CysP6 silenced lines with higher level of IL-10
accumulation in comparison to the IL-10 control. TSP, total soluble protein; Si, silenced
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Figure 3.7: IL-10 accumulation in CysP silenced T0 tobacco lines. IL-10 accumulation
remains lower in comparison to the controls in T0 generation of CysP1-CysP10 (except
CysP6) silenced lines. Y-axis represents the normalized value of IL-10/TSP for different
independent transgenic lines grown at different time period. Blue, red, black and green
bars are normalized against their respective colour coded IL-10 level in IL-10 control
plant. Numbers above the bar represent actual IL-10 level in ng/mg of total soluble
protein in control plants. Si, silenced
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3.6 IL-10 accumulation increases with plant maturity in tobacco
To evaluate if the degree of plant maturity affects the production of recombinant
protein, IL-10 levels in CysP6 silenced lines and IL-10 controls were checked at two
different time points. The plants were grown simultaneously in the greenhouse and IL-10
ELISA was done at 4 weeks and 7 weeks after transfer to the greenhouse. The plants
were approximately 0.5 ft. tall at 4 weeks of age and approximately 1.5 ft. tall at 7 weeks
of age. As shown in Figure 3.8, the levels of IL-10 accumulation in the leaf tissue
increased as plants progressed to maturity in both CysP6 silenced and IL-10 control
plants. Based on this result, to maintain a consistency in experimental approaches, further
experiments were performed using 7 week-old plants. Moreover, no abnormal growth or
any morphological differences were observed for the CysP silenced lines compared to IL10 controls.
3.7 Transient silencing of CysP6 increases IL-10 accumulation
To further examine the effect of CysP6 silencing on IL-10 accumulation levels,
transient expression experiments were performed in tobacco, and transcript and protein
accumulation were studied. CysP6 silencing or vector-only (control) constructs were
transiently delivered to a total of seven, 1.5 ft. tall IL-10 control plants using agroinfiltration of leaf tissue (Figure 3.9A). After 4 days post infiltration, tissues were
collected for both protein and transcript analysis. Unlike in vector-only plants where the
CysP6 transcript was detected by RT-PCR, the CysP6 transcript was undetectable in all 7
biological replicates infiltrated with the silencing construct (Figure 3.9B). This suggests
that CysP6 was efficiently silenced by transient infiltration of the silencing construct. The
same CysP6 silencing construct was used for the generation of stable CysP6 silenced
transgenic tobacco lines as mentioned previously in section 3.5.
To check if IL-10 accumulation changed in response to decreased CysP6 transcript,
IL-10 levels were measured in leaf tissue collected at the same time along with tissue that
was used for RT-PCR.
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Fig 3.8: IL-10 accumulation in tobacco plants of different ages. A) A photograph
showing 7 weeks old CysP silenced tobacco plants in the greenhouse. B) IL-10
accumulation in 4 weeks and 7 weeks old CysP6 silenced tobacco lines. IL-10
accumulation increased consistently in CysP6 silenced lines and IL-10 controls over time.
The numbers indicate different independent CysP6 silenced lines. TSP, total soluble
protein; Si, silenced.
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Fig 3.9: Transient silencing of CysP6 in G7 tobacco. A) 7 Week-old G7 tobacco used
for transient CysP6 silencing experiment. Leaves (4th, 5th and 6th from the top) were
infiltrated and tissue was used to determine CysP6 transcript and IL-10 accumulation. B)
CysP6 expression in CysP6 silencing and vector-only (Si Vec.) infiltrated tissue, 4 days
post infection. The top panel corresponds to Actin (accession no., #AB158612.1) as a
reference gene and the bottom panel corresponds to CysP6 transcript in the biological
replicates (1 to 7). C) IL-10 accumulation levels in CysP6 silencing and vector-only
infiltrated tissues. Numbers on the X-axis represent the biological replicates. D) Change
in IL-10 accumulation due to transient CysP6 silencing. The IL-10/TSP values are the
averages of 7 biological replicates and asterisk (*) represents a significant difference in
IL-10 levels between CysP6-Si and control tissues using student t-test at 95% confidence
level. Si, Silenced; Vec., Vector.
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IL-10 levels were found to be higher in all seven biological replicates which were
infiltrated with the silencing construct, whereas tissue infiltrated with the vector-only
control accumulated lower levels of IL-10 (Figures 3.9C). The difference in IL-10
accumulation between CysP6 silenced and control tissues was found to be statistically
significant (Figure 3.9D). These results also indicate that reduction in CysP6 expression
results in increased IL-10 accumulation.
3.8 Transient overexpression of CysP6 does not reduce IL-10 accumulation
Since silencing of CysP6 increased IL-10 accumulation in both stable and
transient expression systems, overexpression of CysP6 was carried out to see if it would
reduce IL-10 accumulation. IL-10 control plants were transiently infiltrated with CysP6
over-expression or vector-only constructs and IL-10 level was determined 4 days post
infiltration.
As shown in Figure 3.10, it was found that IL-10 accumulation in CysP6
overexpressed tissue was not lower in comparison to the control. Even though a slight
reduction in the levels of IL-10 was observed for CysP6 overexpressed tissues, the
difference was not significant.
In the previous experiment with T0 stable lines, IL-10 accumulation in CysP
silenced plants (except for CysP6-Si, lines) was either unaffected or in some cases lower
than in IL-10 controls (Figure 3.7). To check if overexpressing these CysPs could affect
IL-10 accumulation, full length CysP genes (CysP1, CysP2 and CysP5) were successfully
cloned and transiently overexpressed in IL-10 control plants. Similar methodologies and
conditions were followed as in the transient silencing experiment (section 3.7).
Transiently overexpressing these CysPs did not change IL-10 accumulation, as no
significant difference was observed between IL-10 levels in the overexpression or vectoronly infiltrated tissues (Figure 3.10).
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Figure 3.10: Transient overexpression of CysPs in G7 tobacco. A) Schemetic
representation of overexpression vector with or without CysP gene. Open reading frames
of CysP1, CysP2, CysP5 and CysP6 were cloned into expression vector, pB7WG2D,1. B)
IL-10 level in CysP overexpression (CysP-OE) and vector-only (OE Vec.) samples.
Agrobacterium containing specific CysP expression constructs were infiltrated in G7
tobacco plant and IL-10 level was measured 4 days post infiltration. Data labels above the
bar represent IL-10 accumulation levels. The data were the averages of two biological
replicates for each construct. OE, overexpression; Vec. vector.
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3.9 CysP6 localizes in the ER
To sufficiently produce IL-10 in tobacco, the protein was targeted to the secretory
pathway and retained within the ER. To study the possibility IL-10 being degraded by
CysP6 using the secretory pathway, the intracellular localization of CysP6 was
performed.
A translational fusion of CysP6 and YFP was created and transiently expressed in
N. benthamiana using the methods described in the section 2.5. Protein accumulation was
monitored via confocal microscopy. Confocal microscopy is an optical imaging
technique, which with the help of fluorescent probes, enables visualization of the
intracellular structures and processes occuring inside the cells. Several net-like structures
were seen in CysP6-YFP that resembled the localization pattern for the ER (Figure
3.11A). To confirm if the fluorescence in net-like structures was indeed ER, colocalization of CysP6-YFP fusion protein with ER localizing control (ER-CFP) was
performed. ER-CFP construct contained both ER targeting at the N-terminal and
retention signal sequences (KDEL) fused to the Cterminal end of CFP. Co-expression of
CysP6-YFP and ER-CFP showed overlap of CFP signal with that of YFP from CysP6YFP (Figure 3.11B), thus confirming that CysP6 localizes in the ER in tobacco leaf cells.
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Figure 3.11: ER localization of CysP6. A) Agrobacterium tumefaciens carrying
pCysP6-YFP and pER-CFP plasmids were infiltrated into N. benthamiana and visualized
using confocal microscopy. ER localization of CysP6-YFP is seen in tobacco leaf cells.
White box indicates the region with network like structures. B) Co-expression of CysP6YFP and ER-CFP showing the overlapping of YFP and CFP signals. SP, signal peptide,
Scale bars indicate15 µm. Images shown in A and B are the representatives.
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3.10 Generation of CysP silenced T1 tobacco lines
From the ELISA analyses of T0 plants it had been found that silencing of CysP6
increases IL-10 accumulation. Moreover, silencing of other candidate CysPs lowers or
doesn’t affect IL-10 levels in the T0 plants. To study if the effect of CysP silencing on IL10 accumulation can be stable over generations, T1 plants were generated using seeds
obtained from the T0 CysP silenced plants. As plants segregate for transgenes in
successive generations, seeds from CysP6-CysP10 silenced T0 lines were screened in
BASTA containing medium and genotyping was done to confirm the presence of
transgene in T1 plants (Figure 3.12A and 3.12C). For seeds from CysP1-CysP5 silenced
lines, since the transgenic plants inherit eGFP from the RNAi vector (see 2.4.1 of method
section), selection was done by observing GFP fluorescence under the UV microscope.
As shown in Figure 3.12B, a transgenic line is recognized by visualizing green
fluorescence under the UV.
The T1 transgenic lines were also confirmed by genotyping (3.12C). Genomic
DNA was extracted from at least 2 biological replicates of each CysP silenced T1 line and
primers specific to Cmr gene present in the CysP silencing construct were used for PCR.
Transgenes were present in a total of 64 T1 lines. The numbers of CysP silenced T1 lines
generated for each candidate CysP gene is shown in Table 3.5. All the T1 lines were
grown in the greenhouse and used for IL-10 ELISA analysis when the plants were of
mature height (nearly 1.5 ft. tall).

55

A

B

W

UV

C

Figure 3.12: Generation of CysP silenced T1 tobacco lines. A) Screening of T0 seeds
from CysP silenced tobacco lines. Seeds from CysP6-CysP10 silenced lines were grown
on MS basal medium supplemented with BASTA. B) Screening of T0 seeds from CysP1CysP5 silenced tobacco lines. Seeds were grown in MS basal medium and transgenic
plants were selected by observing GFP fluorescence (green colour) under UV. Images
show a CysP silenced transgenic line under white light (W) and UV. C) Genotyping of
T1 plants By PCR to validate the presence of Cmr gene. A representative gel image
showing amplicon of 520 bp corresponding to Cmr positive lines (contain RNAi
constructs). Empty lane indicated by the asterisk sign corresponds to a Cmr –ve line
(doesn’t contain RNAi construct). Positive PCR control, pB7GWIWG2(II),0 plasmid.

56

Table 3.5: Numbers of CysP silenced T1 tobacco lines.

Candidate
CysP gene

CysP silenced
lines (T1)

Candidate
CysP gene

CysP silenced
lines (T1)

CysP1
CysP2
CysP3
CysP4

9
4
8
3

CysP6
CysP7
CysP8
CysP9

12
9
7
12

CysPAll-Si

1

CysP10

-
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3.11 IL-10 accumulation in CysP silenced T1 tobacco lines
To study the stability of IL-10 accumulation in the CysP silenced tobacco plants,
IL-10 levels were measured for a total of 30 different T1 lines. The production of IL-10
was stable over successive generations of tobacco (Figure 3.13). CysP silenced T1 lines
(CysP1-Si, CysP2-Si, CysP3-Si, CysP4-Si) all showed lower levels of IL-10 in
comparison to their respective IL-10 control plants (represented by same color bars in
Figure 3.13). Lower IL-10 accumulation was also seen for these lines in the T0 generation
(Figure 3.7). In a similar pattern to that seen in the T0 generation, CysP6 silenced T1 lines
showed nearly equal (line 2 and 15) or higher (line 8 and 9) levels of IL-10 accumulation
in comparison to respective control plant. This suggests that, the effect of CysP silencing
on IL-10 accumulation in tobacco remains similar over the next generation.
3.12 CysP6 silenced T1 lines display reduced expression of CysP6
To confirm that the increased IL-10 accumulation in CysP6-Si lines resulted from
reduced CysP6 levels, transcript abundance was quantitated using qRT-PCR. As shown
in Figure 3.14, CysP6 expression was lower in all CysP6-Si lines in comparison to the
IL-10 controls. A comparison of CysP6 silencing and IL-10 accumulation was done
between CysP6 silenced lines and control and the correlation between silencing of CysP6
and resulting IL-10 accumulation was studied. CysP6 transcript was higher (IL-10
control), IL-10 accumulation was lower, and as Cys6 transcript was lower (CysP6Si-9,
CysP6Si-8), IL-10 accumulation was higher. However, a high error was seen in CysP6
expression among CysP6Si-9 and CysP6Si-15 lines. Larger numbers of replicates are
required in-order to relate the degree of CysP6 silencing and accumulation of
recombinant protein in transgenic plants.
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Figure 3.13: IL-10 accumulation in CysP silenced T1 tobacco lines. Normalized IL-10
levels among different CysP-Si T1 lines and controls. Green, blue and yellow colour bars
are normalized to IL-10 levels in their respective respective control plants (IL-10 control,
on the right). Numbers above the bar represent actual IL-10 level in ng/mg of total
soluble protein. Error bars represent the mean of at two biological replicates for all the
lines except CysP6-Si lines 8 and 15 (3 biological replicates).
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Figure 3.14: CysP6 expression and IL-10 accumulation in CysP6 silenced T1 lines. A
comparison between IL-10 accumulation and CysP6 expression levels of CysP6 silenced
lines and controls. Blue bars represent IL-10/TSP normalized to IL-10 control and orange
bars represent fold expression of CysP6 normalized to Actin. Three biological replicates
were used for all the lines and control except for lines 2 and 9 (2 biological replicates).
Error bars represents the standard deviation.
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Chapter 4: Discussion
CysPs are known to be the major proteases that affect the total yields of
recombinant proteins in plants. However, none of the CysPs that are implicated in the
regulation of recombinant protein accumulation have been reported so far in tobacco,
despite the fact that tobacco is an ideal platform for protein production. In this study, the
role of tobacco CysPs in regulating recombinant IL-10 accumulation in transgenic
tobacco was investigated. The results obtained are discussed below.
4.1 Identification of CysPs involved in IL-10 proteolysis
To identify CysPs that potentially alter IL-10 accumulation in tobacco, all the
expressed CysPs were identified by searching the TGI database. Since the tobacco
genome sequence has not been published yet, the TGI database is the only major source
of information regarding gene sequences and their tissue specific expression. At least 60
putative CysPs were identified in tobacco (Table 3.1 and Table 3.2). The total number of
CysPs may change as more ESTs are deposited in the database or after the availability of
whole genome sequence of tobacco. Out of 32 tentative contig sequences available for
CysPs, 9 contained full open reading frame.
The CysP gene family in tobacco appears to be a large gene family, and is
comparable to that of other plants such as Arabidopsis (38 CysP genes) and Populus (44
CysP genes) (Garcia-Lorenzo et al., 2006). Evolutionarily, tobacco (N. tabacum)
originated from an interspecific cross of two wild forms, N. sylvestris and N.
tomentosiformis. The interspecific cross between two diploid species with equal number
of chromosomes (12 pairs each) resulted into a fertile amphiploid carrying a total of 24
pairs of chromosomes (Leitch et al., 2008). The larger number of CysPs in tobacco could
have resulted from the preservation of CysPs from both of the parents. Many of these
CysPs may have critical roles in normal plant growth and development and responses to
biotic and abiotic factors that have been characterized in many plant species including
tobacco (Grudkowska and Zagdanska, 2004). CysPs are known to initiate and mediate
storage protein degradation in germinating cereal seeds (Kato and Minamikawa, 1996).
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For example, rice REP-1 digests the rice seed storage protein glutein in vitro, and is
regulated by giberellic acid in germinating seeds (Ho et al., 2000). The expression of
tobacco the CysP, NtCP23, was enhanced during senescence and is similar to what is
seen in other plant senescence associated CysPs and mammalian Cathepsin H (Ueda et
al., 2000). Degradation of proteins during senescence is essential for amino acid
remobilization. Similarly, CysPs have been implicated in cold, drought and wounding
stress (Schaffer and Fischer, 1988; Koizumi et al., 1993; Linthorst et al., 1993) , as well
as during programmed cell death (Ling et al., 2003; Zhao et al., 2013).
Out of 55 putative CysPs identified in the EST database, CysP1-CysP10 were
selected for characterization because they were known to be expressed in leaves and had
a complete sequence availability in the EST database. These CysPs were of primary
interest as they may target IL-10 expressed in the tobacco leaves. As shown in Table 3.1,
41 out of 55 putative CysPs were found to be expressed in leaf, which was considered as
either in leaf only or seedling or in pooled sample of leaf, flower and root tissues. Eight
out of these 41 (CysP1, CysP2, CysP4, CysP5, CysP6, CysP7, CysP8 and CysP10)
consisted of complete open reading frames and their putative protein sequences contained
peptidase_C1 domain (Figure 3.1). Peptidase_C1 is also called papain domain, as the
name is given to all the CysPs containing Cys, His and Asn amino acid residues in their
catalytic triad and was first characterized in Papaya proteinase 1 from Carica papaya
(Grzonka et al., 2001). Many papain family CysPs have been characterized in plants and
animals that are known to degrade indigenous and foreign proteins (Shenai et al., 2000;
Outchkourov et al., 2003).
The papain family tobacco CysPs consist of 38-250 long propeptide sequence and
are possibly synthesized as precursor CysPs (Grudkowska and Zagdanska, 2004) (Figure
3.1 and Table 3.3). Their papain domain comprised 220-260 amino acids and might
represent the mature enzyme. Activation of papain CysPs is effected by intra- or intermolecular proteolysis, where the propeptide sequence is cleaved off (Wiederanders et al.,
2003). CysP6 and CysP8 contain an extra GRN motif, the role of which in plant is not
well understood, but is implicated in protein-protein interactions, targeting and/or activity
regulation inside the cell (Tolkatchev et al., 2001). In Arabidopsis, GRN is removed by
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autocatalysis in RD21, a CysP involved in plant immunity and senescence. However, in
an in vitro condition, removal of GRN is not necessarily required for enzyme activation
(Gu et al., 2012).
CysP9 is an otubain CysP. CysP9 is predicted to contain a large OTU domain, and
Asp, Cys and His residues in its putative catalytic triad. Proteins containing such domain
are classified as deubiquitinating enzymes, and have been shown to play a role in
removing ubiquitin from the proteins that are bound for degradation in proteasomeubiquitin pathway (Balakirev et al., 2003), suggesting a similar role for CysP9 in tobacco.
As shown in Table 3.2, five additional full length CysP sequences were identified
and characterized in tobacco, bringing the total to at least 60 CysPs. These sequences
were not represented in the TGI database, suggesting the possibility of additional CysPs.
The release of the whole genome sequence of tobacco will help in the genome-wide
identification of CysPs genes. These five additional sequences showed a high degree of
amino acid identity with the TC sequences in the TGI database, and were expressed
mostly in tobacco leaf tissue. NtCP1 was expressed only in senescing leaf and is likely a
senescence marker in tobacco plant (Beyene et al., 2006). NtCP2 is a CysP with KDEL
signal in its C-terminal and was expressed in the mature tobacco leaves (Beyene et al.,
2006). NtCP56 was strongly expressed in anthers and was involved in pollen grain
development (Zhang et al., 2009). CyP7 and CyP8 were weakly expressed in leaf tissue
and their transcript accumulation increased by six fold in response to wounding,
indicating that they are possibly stress related CysPs (Linthorst et al., 1993). A very high
degree of amino acid identity was found between NtCP56 and CysP10 (99.17%), with
changes in three amino acid residues (Iso162 to Tyr, Ser172 to Pro, Lys306 to Arg). At
the nucleotide level, NtCP56 is 98.6% identical to CysP10 with the sequence coverage of
66.6% of CysP10, suggesting that they are not the same CysPs. However, as NtCP56 and
CysP10 share very high degree of amino acid identity, it can be speculated that these two
CysPs are protein isoforms in tobacco. CyP7 and CyP8 showed similarity to TC131927,
which is surprisingly not included in the list of 55 putative CysPs, but was found as the
result of BLAST with the TGI database by using the respective nucleotide sequence as
the query sequence.
63

4.2 ERFNIN motif and catalytic triad is conserved in papain family tobacco CysPs
Sequence alignment of the papain family candidate CysPs, which also included
two previously characterized NtCP6 and NtCP23, showed a conserved ERFNIN motif in
their propeptide sequence (Figure 3.2). The ERFNIN motif is shared by CysPs from
diverse group of species, ranging from protozoa to mammals, and has been mostly
reported in mammalian cathepsin H and L type proteins (Karrer et al., 1993). Mammalian
cathepsins are known to carry out different intracellular and extracellular functions that
require right balance of enzyme activation from precursor CysPs. Intracellularly, they
function in apoptosis, antigen and protein processing .Whereas extracellularly, they
contribute directly to the degradation of foreign proteins and the extracellular matrix
(Dickinson, 2002). The signature ERFNIN motif is thought to be associated mostly with
inhibiting protease activity before enzyme activation is required.
Also seen in the amino acid alignment, a conserved catalytic triad comprising of
Cys25, His159 and Asn175 residues was found in all the candidate papain family CysPs.
Enzymatic activity of CysP is dependent on Cys25 and His159 residues, which exist as
ion-pairs in a pH interval of 3.5-8 (Grzonka et al., 2001). The role of Asn175 in the
catalytic triad is not understood well, but is thought to be responsible in maintaining
structural integrity of the enzyme, as it is conserved across all papain family CysPs
(Vernet et al., 1995). Besides catalytic Cys residue, four other Cys residues were also
identified to be conserved in the papain domain of all aligned CysPs. These residues are
likely involved in disulfide bridge formation, thus in proper folding and activity of the
enzyme.
4.3 CysP6 is involved in reducing IL-10 accumulation in tobacco
Quantitative analysis of IL-10 levels in CysP6 silenced tobacco lines showed
increased accumulation compared to the IL-10 control (Figure 3.6). Some CysP6 silenced
lines showed no change in IL-10 accumulation while others accumulated lower level of
IL-10 in comparison to the IL-10 control plant. Thus, the accumulation of recombinant
protein varied across different CysP6 silenced lines. The variation in the IL-10 levels
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could have resulted from a position effect or differential levels of CysP6 gene silencing
(also seen in CysP6 expression levels in different CysP6 silenced T1 lines, Figure 3.14).
Such a position effect has been explained by researchers in several transgenic plants and
animals (Matzke and Matzke, 1998).
Silencing indigenous tobacco putative CysPs; CysP1, CysP2, CysP3, CysP4,
CysP5, CysP7, CysP8, CysP9 and CysP10 did not increase IL-10 accumulation (Figure
3.7). Surprisingly, in all of these CysP silenced T0 independent transgenic lines, the level
of IL-10 accumulation remained lower in comparison to that of the IL-10 control plant.
Since silencing these CysPs didn’t result in an increase in IL-10 accumulation, no further
characterization was done with these respective transgenic lines. However, performing a
detailed transcript analysis of all candidate CysPs can be done in-order to know if and to
what extent these CysPs are silenced, and how does silencing relate to IL-10
accumulation seen in the individual silenced lines. More work is required to reach
conclusions regarding their role in recombinant protein accumulation in tobacco.
4.4 IL-10 accumulation in tobacco increases with plant maturity
Inherent factors affecting synthesis and accumulation of IL-10 have been
characterized in detail in Arabidopsis (Chen et al., 2013). To study if physical parameters
such as age and height of the plant affect IL-10 accumulation, IL-10 content was
measured at two different time points (Figure 3.8). In 7 week-old tobacco, the plants
accumulated a higher amount of IL-10 in all the transgenic lines in comparison to the 4
weeks old plants, which suggests that IL-10 production increases with plant maturity.
For the production of IL-10 in tobacco, the recombinant protein requires
harvesting before the flowering stage of the plant. Therefore, IL-10 levels in plants older
than 7 weeks were not determined. Moreover, after flowering the expression of
senescence associated genes could pose a problem in recombinant protein accumulation,
as protease activities are high in senescessing organs. Higher protease activity during leaf
senescence has been reported in many plants including tobacco and CysPs are known to
be responsible for it (Ueda et al., 2000; Beyene et al., 2006).
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To minimize the possible error that can arise due to differences in transgene
expression between young and mature leaves of the same plant, IL-10 level for each line
was averaged from fully expanded 4rd, 5th and 6th leaves from the top, thus excluding
variability caused during sampling, if any.
4.5 Transient knockdown of CysP6 in tobacco leaf
Identification of CysP6 as a potential candidate involved in affecting recombinant
protein accumulation is a first reported case in tobacco. To study further the effects of
silencing CysP6 on the accumulation of CysP6 transcript and subsequent IL-10 levels in
tobacco, a transient experiment was performed. Transient expression of the CysP6 RNAi
construct resulted in near to invisible levels of CysP6 transcript and significantly
increased the accumulation of IL-10 in tobacco (Figures 3.9B and D). This also
confirmed the putative role of CysP6 in determining the yield of foreign protein, which
was also seen in stable silenced lines.
With the post-genomic era and a flooding of gene sequences, several ways have
been explored to assign putative gene functions. Because of its efficiency and specificity,
RNAi is one of the widely used techniques in determining gene function. Most of the
RNAi approaches utilize generation of stable transgenic lines and observation of RNAi
phenotypes related to the particular genes. However, generation of stable lines usually
requires a long time, which may range from 2-6 months depending on the type of plants
used (4 months in tobacco, see Figure 3.4). Using Agrobacterium-mediated transient
expression of the silencing construct, gene functions can be determined in a short period
of time. As seen in this study, transient silencing of CysP6 could be achieved in nearly a
week, which is very short compared to the time required to generate stable transgenic
tobacco lines. Transient silencing of indigenous genes via agro-infiltration had been
reported so far in plant species such as Vitis vinifera (Bertazzon et al., 2012), but not in
tobacco. Particularly with the results seen here, transient RNAi can be efficiently utilized
for gene functional assays in tobacco.
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4.6 CysP6 localizes to the ER
CysP6 fused to YFP showed that it is localized to the ER. It was interesting to see
that CysP6 is localized in the ER, without the presence of C-terminal ER retrieval signal
sequence KDEL or HDEL in its C-terminal end (see Figure 3.2 for CysP6 sequence).
However, CysP6 consists of a signal peptide with predicted cleavable position between
26th (Ala) and 27th (Ser) residues in its amino acid sequence. Localization of the proteins
with the signal peptide can possibly be in the ER lumen, ER membrane, tonoplast, cell
membrane or extracellular space and are collectively processed through the secretory
pathway involving ER as the initial component. Several ER resident proteins that lack the
retention signal are known to localize in the ER in a signal-independent fashion (Gu et
al., 2012). Arabidopsis RD21 is one of such protein without KDEL sequence, and is
localized to the vacuole and ER in response to osmotic stress and wounding (Gu et al.,
2012). Some of these proteins retained in the ER also play a role in quality control
through an interaction with the ER chaperones, whose function is to retain and
subsequently degrade assembly defective proteins (Hammond and Helenius, 1995).
Accumulation of proteins targeted to the ER has been reported to be affected by
plant proteases (Stevens et al., 2000). It was shown that IgG1 targeted to accumulate in
the ER is possibly degraded by acidic proteases, most of which consisted of senescence
associated CysPs (Stevens et al., 2000). A study by Sharp and Doran (2001) indicated
that initiation of the antibody IgG1 degradation in a transgenic tobacco cell suspension
culture occurs along the secretory pathway outside the ER (Sharp and Doran, 2001).
Localization of CysP6 to the ER provides greater possibility of its involvement in IL-10
degradation, since IL-10 accumulates in the ER. The degradation process might be
occurring along the secretory route when IL-10 is being processed or accumulated.
However, more study should be conducted regarding the fate of IL-10, to prove the
speculation that IL-10 degradation occurs along secretory pathway, thus affecting its
overall yield in tobacco plant.
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4.7 CysP6 silenced lines show reduced CysP6 expression in T1 generation
CysP6 expression was measured in four CysP6 silenced T1 lines (2, 8, 9 and 15)
by qRT-PCR and it was found that the CysP6 transcript level was lower in all four lines
in comparison to the IL-10 control plant (Figure 3.14). The normalized fold expression of
CysP6 varied among the lines, suggesting that the degree of CysP6 silencing was
different in each line. The differential level of silencing is a common character of RNAimediated gene silencing in plants (Kerschen et al., 2004). Multiple genes were silenced in
Arabidopsis using different RNAi constructs, which showed significant transcript
variability between the independent RNAi lines of same target gene (Kerschen et al.,
2004). In tobacco, the degree of gene silencing was analyzed in three independent lines
carrying 35S- β-Glucorinidase (GUS) transgenes, and it was found that the amount of
antisense GUS RNA co-related with the extent of post-transcriptional silencing in each
line (Hamilton and Baulcombe, 1999). Differential silencing was also observed in the
expression of rice CysP (OSEP3A, encodes REP1), as small interfering (si) RNA was
targeted to silence OSEP3A in transgenic rice cell lines expressing recombinant hGMCSF (Kim et al., 2008).
The expression of siRNA and the silencing of a target gene depend on several
factors, collectively referred to as the “position effect” (Matzke and Matzke, 1998). Such
an effect is caused by the telomeric (stable expression) or centromeric (mosaic
expression) integration of transgenes in the chromosome and transfer of the binary vector
sequences that reduces transgene expression (Matzke and Matzke, 1998). Differential
silencing of CysP6 seen in the T1 tobacco plants, which were obtained from the T0
independent transgenic lines, might also be a result of the position effects.
A comparison of CysP6 expression and IL-10 accumulations in the CysP6
silenced T1 lines showed no correlation. In the plants with lower CysP6 expression (line 8
and 9), IL-10 accumulation was higher in comparison to the controls. Two of the CysP6
silenced lines showed higher error in expression levels of CysP6 (line 9 and 15), thus
their relation to corresponding levels of IL-10 is not conclusive. A higher number of
stable lines and biological replicates should be included to draw a conclusion regarding a
68

correlation, which might exist between the degree of CysP6 silencing and resulting IL-10
accumulation in tobacco.
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Chapter 5: Perspectives and Future work
Plants have emerged as major choice in producing biopharmaceutical proteins.
High production costs hamper other production systems such as microbial fermentation
or animal-based systems. Using plants, higher yields and economic production of
recombinant proteins can be achieved by creating stable transgenic lines that can simply
be propagated using agriculture.
Identification of the members of the tobacco CysP family is the first step in
exploring the potential roles of many CysPs in plant growth and cellular responses to
environmental stimuli, including foreign protein antigens. With at least 60 putative
CysPs, the tobacco CysP gene family is possibly one of the largest plant CysP families.
As plant CysPs are reported to be involved in the degradation of many heterologous
proteins, it is necessary to understand the role of tobacco CysPs in IL-10 proteolysis.
Identifying a CysP involved in the degradative process is a major step towards alleviating
protease effects and improving protein yields in tobacco. Out of 10 candidate CysPs
chosen for study, CysP6 was found to be potentially involved in IL-10 proteolysis. Stable
silencing of CysP6 resulted in an increase in IL-10 accumulations over two generations of
tobacco. The potential link of CysP6 to IL-10 degradation was also established by
transiently silencing CysP6. Further characterization of CysP6 is necessary to confirm a
direct role in IL-10 degradation, which can be done by using activity-based protein
profiling (ABPP) techniques (van der Hoorn et al., 2004; Cravatt et al., 2008). More
evidences can be generated by doing CysP activity assay and it can help to verify that
functional protease activity is lower in CysP6 silenced lines in comparison to the IL-10
control plants. Confirmation of CysP6 roles could open opportunities such as creating
CysP6 depleted tobacco lines that can be utilized to study the accumulation of other high
value therapeutic proteins.
As shown in Figure 3.14, IL-10 accumulation in the T1 generation of CysP6
silenced lines and a differential CysP6 expression in their respective biological replicates
indicated the inconclusive correlation between degree of CysP6 silencing and resulting
IL-10 accumulation. A higher number of stable transgenic lines and biological replicates
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should be analyzed to study correlation between degree of CysP6 silencing and IL-10
accumulation. Moreover, even though the silencing construct was targeted to the unique
region in CysP6, it is reasonable to study if silencing is specific to CysP6 only. The study
of silencing specificity can be done by a transcript level analysis of all other candidate
CysPs in the CysP6 silenced lines. It will be helpful to know if CysPs other than the
CysP6 have a potential impact in IL-10 accumulation.
Subcellular localization of CysP6 in the ER, even without presence of an ER
retention signal, could be due to presence of a signal peptide which directs proteins to the
secretory pathway and is functionally required to perform roles similar to the ER resident
proteases. ER resident proteins are involved in degradation of proteins and some of them
lack an ER retention signal (Gu et al., 2012). Based on CysP6 localization study, it is
plausible that ER could potentially be the site of IL-10 proteolysis as IL-10 is also
targeted to accumulate in the ER. To confirm that IL-10 is degraded in the ER,
subcellular fractioning can be done followed by immunoblotting with anti-IL-10
antibodies.
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